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ABSTRACT 
Species belonging to the genera Streptomyces and Mycobacterium are well known for their 
contrasting lifestyle and impact on humans. Streptomyces species produce two-thirds of 
antibiotics, secondary metabolites, used in the world, whereas mycobacterial species are well 
known to be the deadliest human pathogens, although a few are environmentally useful. 
Mycobacterial species also produce secondary metabolites that play a role in pathogenesis. It is a 
well known fact that genes involved in the synthesis of secondary metabolites form clusters known 
as biosynthetic gene clusters (BGCs). To date, comparative analysis of secondary metabolite 
BGCs in species belonging to these two genera has not been reported. Among the genes involved 
in synthesis of secondary metabolites, cytochrome P450 monooxygenases (CYPs/P450s) play a 
key role, as these enzymes contribute to the diversity of secondary metabolites owing to their 
chemo-, stereo- and regio-specific oxidation of substrates. Despite this importance of P450s in the 
synthesis of secondary metabolites, to date, identification of P450s involved in the synthesis of 
secondary metabolites in species belonging to these two genera has not been reported. Thus, this 
study is aimed at addressing these two research gaps by conducting comprehensive comparative 
analysis of secondary metabolite BGCs and associated P450s in the species belonging to the genera 
Streptomyces (48 species) and Mycobacterium (60 species).  
Genome-wide analysis revealed the presence of a large and diverse number of secondary 
metabolite BGCs in Streptomyces species compared to mycobacteria species. In total 1 461 
secondary metabolite BGCs belonging to 159 types were found in 48 Streptomyces species 
compared to 898 secondary metabolite BGCs belonging to only 18 types found in 60 
mycobacterial species. Among Streptomyces species, S. griseochromogenes has the highest 
number of secondary metabolite BGCs (49) and Streptomyces sp. 4F has the lowest number of 
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secondary metabolite BGCs (19) in their genomes. Mycobacterium marinum has the highest 
number of secondary metabolite BGCs (29) and two strains of M. leprae have the lowest number 
of secondary metabolite BGCs (five each) in their genomes. Quite a big difference was observed 
with respect to the types of secondary metabolite BGCs between Streptomyces and mycobacterial 
species. Among 159 types of secondary metabolite BGCs found in Streptomyces species, only 13 
types of BGCs contributed 80% to the total percentage of BGCs, suggesting that the secondary 
metabolites produced by these BGCs were highly important in Streptomyces species’ physiology. 
The secondary metabolite BGC, terpene, was dominant, followed by siderophores, nonribosomal 
peptides (Nrps) and Type 1 polyketides (T1pks) in Streptomyces species. Among 18 types of 
secondary metabolite BGCs identified in mycobacterial species, Nrps was the dominant secondary 
metabolite BGC, followed by ‘other’, T1pks and T1pks-Nrps. Despite the presence of 15 common 
types of secondary metabolite BGCs between the genera Streptomyces and Mycobacterium, large 
differences were observed in terms of the number of BGCs, indicating that the selective enrichment 
of particular secondary metabolite BGCs in both genera is possibly due to the different lifestyle, 
as discussed in the subsequent section. 
Comparative analysis of P450s that are part of secondary metabolite BGCs revealed the 
presence of a large number of diverse P450s as part of these secondary metabolite BGCs in 
Streptomyces, compared to Mycobacterium. Not all secondary metabolite BGCs found in 
Streptomyces and Mycobacterium have P450s. Among 1 461 Streptomyces species, only 554 
secondary metabolite BGCs were found to have P450s, whereas in mycobacterial species, among 
898 only 204 secondary metabolite BGCs have P450s. Overall, 554 and 204 P450s were found to 
be part of secondary metabolite BGCs in respectively Streptomyces and mycobacterial species. 
Among 88 P450 families that are part of different secondary metabolite BGCs, some P450 families 
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are highly dominant in Streptomyces species, indicating their key role in the synthesis of different 
secondary metabolites. These P450 families were found to be the same that are highly populated 
in Streptomyces species, with some exceptions. This strongly indicates that these P450 families 
provide an advantage to Streptomyces species by generating diverse secondary metabolites, thus 
letting these species thrive in nature. Mycobacterial species’ secondary metabolite BGC P450 
profiles are contrasted with Streptomyces species, where the dominant P450 families are not 
necessarily dominant as part of secondary metabolite BGCs. Ten P450 families, namely CYP51, 
CYP123, CYP125, CYP130, CYP135, CYP136, CYP138, CYP140, CYP144 and CYP1128, are 
conserved and highly populated across 60 mycobacterial species. However, none of these P450 
families is dominant as part of different secondary metabolite BGCs. The CYP139 P450 family 
was found to be the dominant family as part of secondary metabolite BGCs. Although eight P450 
families, namely CYP124, CYP121, CYP105, CYP125, CYP102, CYP147, CYP136 and 
CYP161, which are part of secondary metabolite BGCs, were commonly found between the genera 
Streptomyces and Mycobacterium, the number of P450s in these families was found to be different.  
Based on the above data, it is clear that different lifestyles influenced the gene content in 
Streptomyces and Mycobacterium, hence differences in the number and type of secondary 
metabolite BGCs and P450s that are associated with secondary metabolite BGCs were observed. 
The saprophytic and symbiotic lifestyle of Streptomyces resulted in the highest diversity of 
secondary metabolite BGCs and P450s, thus helping these organisms to generate chemically 
diverse secondary metabolites to adapt to different ecological niches. For this reason, Streptomyces 
species have been found to have large and diverse secondary metabolite BGCs and P450s 
compared to mycobacterial species.  Based on the evidence presented in this study, the researcher 
hereby proposes that lifestyle or ecological niches play a key role in the evolution of secondary 
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CHAPTER 1: INTRODUCTION 
1.1. Introduction 
Cytochrome P450 monooxygenases (CYPs/P450s) are heme thiolate enzymes that are 
ubiquitously present in species belonging to all biological kingdoms (Nelson, 2018) and even in 
non-living entities such as viruses (Lamb et al., 2009). P450s are well-known for their chemo-, 
regio- and stereo-specific oxidation of substrates with immense catalytic diversity (Sono et al., 
1996, Bernhardt, 2006). P450s have been found to be involved in the synthesis of secondary 
metabolites (Podust and Sherman, 2012, Greule et al., 2018). Secondary metabolites are natural 
products that are widely used in human and veterinary medicine, agriculture and manufacturing, 
and are known to mediate a variety of microbe-host and microbe-microbe interactions 
(Cimermancic et al., 2014, Mthethwa et al., 2018). The genes that produce these metabolites have 
been found to present as a clusters known as secondary metabolite biosynthesis gene clusters 
(BGCs) (Medema et al., 2015). According to Medema et al. (Medema et al., 2015), a BGC can be 
defined as a physically clustered group of two or more genes in a particular genome that together 
encode a biosynthetic pathway for the production of a specialised metabolite (including its 
chemical variants). Bacteria, fungi and plants are known to possess different types of BGCs 
producing a variety of secondary metabolites that are beneficial to humans. Among the genes that 
are part of a BGC, P450s play a key role in contributing to the diversity of secondary metabolites 
owing to their regio- and stereo-specific oxidation (Greule et al., 2018).  
The bacterial phylum Actinobacteria encompasses organisms that are adapted to different 
lifestyles; these may be pathogens (e.g. Corynebacterium, Mycobacterium, Nocardia, 
© Central University of Technology, Free State
16 
Tropheryma, and Propionibacterium), soil inhabitants (Streptomyces), plant commensals 
(Leifsonia), or gastrointestinal commensals (Bifidobacterium) (Ventura et al., 2007). Organisms 
belonging to the genera Mycobacterium and Streptomyces are of particular interest, as the former 
are well known human pathogens (do Nascimento et al., 2016) and the latter are well known for 
producing most of the antibiotics used in the world (de Lima Procópio et al., 2012, Hasani et al., 
2014).  
1.2. Problem statement and rationale of the study 
It is well established that the lifestyle of organisms influences their gene content. The genera 
Mycobacterium and Streptomyces both belong to the phylum Actinobacteria, yet species in these 
genera are well known for their contrasting lifestyles, despite some similarities (Scherr and 
Nguyen, 2009). Mycobacterium tuberculosis H37Rv, the causative agent of tuberculosis (TB), has 
been found to produce different secondary metabolites that play a key role in pathogenesis (Quadri, 
2014). The secondary metabolites produced by Streptomyces are currently used for treating human 
diseases (de Lima Procópio et al., 2012). However, to date, comprehensive comparative analysis 
of different secondary metabolites’ BGCs in both genera, Mycobacterium and Streptomyces, has 
not been reported. Furthermore, despite knowing that P450s play a key role in synthesis and 
attributing the diversity to secondary metabolites (Greule et al., 2018), to date, P450s involved in 
the synthesis of different secondary metabolites in both genera, Mycobacterium and Streptomyces, 
are not known.  Thus, this study is aimed at addressing both research gaps. 
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1.3. Aims and objectives of the study 
1.3.1. Aim of the study 
To perform comparative analysis of secondary metabolite biosynthetic gene clusters and 
associated P450s in the genera Mycobacterium and Streptomyces. 
1.3.2. Objectives of the study 
(i) Genome data-mining and identification of secondary metabolite biosynthetic gene clusters in 
Mycobacterial species. 
(ii) Genome data-mining and identification of secondary metabolite biosynthetic gene clusters in 
Streptomyces species. 
(iii) Annotation and comparative analysis of secondary metabolite biosynthetic gene clusters in 
species belonging to the genera Mycobacterium and Streptomyces. 
(iv) Identification and annotation of P450s involved in the synthesis of secondary metabolites in 
species belonging to the genera Mycobacterium and Streptomyces. 
(v)  Comparative analysis of P450s involved in synthesis of secondary metabolites in species 
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CHAPTER 2: LITERATURE REVIEW 
 
2.1. Secondary metabolites 
All living organisms perform biochemical reactions in order to sustain their lives. The sum of all 
the biochemical reactions carried out by an organism is known as metabolism. The molecules 
involved in these reactions are known as metabolites. Metabolites are of two types: primary and 
secondary metabolites. The metabolites that are required for the growth and maintenance of 
cellular function are called primary metabolites, while metabolites that are not required for the 
growth and maintenance of the cellular functions and are the end products of primary metabolism 
are called secondary metabolites. Secondary metabolism produces secondary metabolites and is 
connected to primary metabolism by using building blocks and biosynthetic enzymes derived from 
primary metabolism (Figure 2.1). 
The term secondary metabolism, first used by plant physiologists more than three decades  
ago (Campbell, 1985), comprises all parts of metabolism specific to certain organisms. In the ideal 
case, secondary metabolites correspond to the following criteria: 
(i) They appear only in a small, systematically defined, group of organisms (family, genus, 
species). 
(ii) In all chemical groups, one finds large variability. This variability can appear in the same or in 
different organisms. 
(iii) No effect of secondary metabolites on the producing organism is recognisable. 
 




Figure 2. 1 Diagram showing connection between production of secondary metabolites and 
primary metabolism (taken from https://nptel.ac.in/courses/102103016/module4/lec31/2.html). 
2.2. Classification of secondary metabolites  
No standard classification is available for secondary metabolites because of their immense 
diversity in structure, function and biosynthesis (McMurry, 2014). Secondary metabolites can be 
classified on the basis of chemical structure (for example, having rings, containing a sugar), 
composition (containing nitrogen or not), their solubility in various solvents, or the pathway by 
which they are synthesised (e.g., phenylpropanoid, which produces tannins). McMurry (2014) 
classified secondary metabolites into five main classes: terpenoids and steroids, fatty acid-derived 
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substances and polyketides, alkaloids, non-ribosomal polypeptides, and enzyme cofactors  (Figure 
2.2).  
Figure 2. 2 Classification of natural products (McMurry, 2014). 
Charactersitics of different groups of secondary metabolites (McMurry, 2014): 
 Alkaloids – contain a basic amine group in their structure and are derived biosynthetically
from amino acids.
 Fatty acid-derived substances and polyketides – biosynthesised from simple acyl
precursors such as acetyl CoA, propionyl CoA, and methylmalonyl CoA. Natural
compounds derived from fatty acids generally have most of the oxygen atoms removed but
polyketides often have many oxygen substituents remaining.
 Nonribosomal polypeptides - peptidelike compounds that are biosynthesised from amino
acids by a multifunctional enzyme complex without direct RNA transcription.
 Enzyme cofactors – do not fit one of the other general categories of natural products and
are usually classed separately. One example is pyridoxal phosphate.
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Hernández-Alvarado et al., (2018) classified secondary metabolites into four main groups: 
terpenes, phenolic compounds, glycosides and alkaloids (Table 2.1) (Hernández-Alvarado et al., 
2018). The main function of different groups of secondary metabolites, examples of metabolites, 
are listed in Table 2.1. 
Table 2. 1 Classification of secondary metabolites (Hernández-Alvarado et al., 2018).  
Group Compounds present Main features 
Alkaloids Hormones, carotenoid pigments, 
sterols, latex and essential oils. 
Group of major importance with more 
than 40 000 molecules, which are 
considered of importance for the 
survival of plants. They are insoluble in 




Coumarins, flavonoids, lignin 
and tannins. 
They are derived from a phenol group. 
Glycosides Saponins, cardiac glycosides, 
cyanogenic glycosides and 
glucosinolates. 
They arise from the condensation of a 
sugar molecule with another containing 
a hydroxyl group, thus forming a 
glycosidic bond. Group with about 
15 000 secondary metabolites. 
Terpenes Quinoline, isoquinoline, 
indole, tropane, 
quinolizidine, piperidine, 
They are soluble in water, contain at 
least one nitrogen atom and exhibit 
biological activity. Most are 
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purine, pyrrolizidene. heterocyclic and some are aliphatic 
compounds. 
 
2.3. Functions of secondary metabolites 
Secondary metabolites play a key role in organisms that produce them. Extensive literature is 
available detailing the functions of secondary metabolites. Demain and Fang (2000) summarised 
secondary metabolites’ functions into five main categories: (i) as competitive weapons used 
against other bacteria, fungi, amoebae, plants, insects, and large animals; (ii) as metal-transporting 
agents; (iii) as agents of symbiosis between microbes and plants, nematodes, insects, and higher 
animals; (iv) as sexual hormones; and (v) as differentiation effectors. In the case of plants, some 
secondary metabolites (including antibiotics) stimulate spore formation and inhibit or stimulate 
germination (Demain and Fang, 2000). 
2.4. Applications of secondary metabolites 
Living organisms produce a range of secondary metabolites with exotic chemical structures and 
diverse metabolic origins. Many of these secondary metabolites find use as natural products in 
medicine, agriculture and manufacturing (Medema et al., 2015). Secondary metabolites have broad 
applications; they serve especially as fighting tools against human pathogens and human disease. 
A summary of applications of different groups of secondary metabolites is listed in Table 2.2.
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Table 2. 2 Applications of secondary metabolites (Hernández-Alvarado et al., 2018). 
Group Pharmaceutical properties 
Alkaloids Anticarcinogenic, antiulcerous, antimalarial, antimicrobial, etc. 
Phenolic 
compounds 
Antidiarrhoeals, antitumourals, antibacterials, antivirals and enzyme 
inhibitors. 
Glycosides Antimicrobials, fungicides, insecticides, anticancer, anti-inflammatory 
and allelopathic. 
Terpenes At high doses, most are very toxic; however, at low doses they work as 
muscle relaxants, tranquillizers, antitussives or analgesics. 
2.5. Applications of microbial secondary metabolites 
Microbes, especially species belonging to the phylum Actinobacteria, are well-known producers 
of different secondary metabolites with properties valuable to humans (Ventura et al., 2007). 
Among the genera in Actinobacteria, genus Streptomyces species are well known to produce a 
large number of secondary metabolites applied in most of the antibiotics used today (Table 2.3) 
(de Lima Procópio et al., 2012). The microbial secondary metabolites have a large number of 
applications in humans to fight human pathogens and human diseases. Thirumurugan and co-
workers (Thirumurugan et al., 2018) provided extensive information on the application of 
microbial secondary metabolites. Thus, in brief, microbial secondary metabolites serve as 
antibioitics, antitumour agents, pharmacological and nutraceutical agents, enzymes and enzyme 
inhibitors and agricultural and animal health products (Thirumurugan et al., 2018).
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Table 2. 3 General information on applications of Streptomyces species. If information is available, secondary metabolites and their 
applications are also presented in the table.  
Species name Specie characteristic or well-known for Reference(s) 
Streptomyces coelicolor It is involved in breaking down organic material in the soil and responsible for 
producing most of the antibiotics in use today, as well as some immunosuppressant 
and anti-tumour agents. It has also been used in genetic engineering studies. 
(Bilyk et al., 
2013) 
Streptomyces avermitilis It produces certain secondary metabolites, namely avermectin, which is a potent 
agent against a wide array of nematodes and arthropod parasites. 
(Witt and 
Stackebrandt, 
1990, Bentley et 
al., 2002) 
Streptomyces griseus It produces streptomycin, a broad-spectrum antibiotic, which has been used for the 
treatment of various diseases, such as TB and the plague caused by Yersinia pestis. 
The organism has also been reported to contain a gene cluster that includes 
fredericamycin, an anticancer drug. 
(Distler et al., 
1992, Ohnishi et 
al., 2008, 
Wendt-




Streptomyces globisporus It produces the antitumour angucyclines landomycin A and landomycin E and 
enediyne antitumour antibiotic C-1027. 
(Rebets et al., 
2003) 
Streptomyces scabiei It is a plant pathogen causing corky lesions to form on tuber and root crops, as well 
as decreasing the growth of seedlings. Along with other closely related species it 
causes potato diseases. It can produce several related toxins, which are mainly 
responsible for its pathogenicity and moreover, S. scabiei produces toxins called 
thaxtomins, which cause hypertrophy and cell death in host plant tissues and are 
essential for pathogenicity. 
(Beattie, 2007) 
Streptomyces sp. Sirex AA-
E 
It is an aerobic microbe that is a prominent member of a bacterial/fungal symbiotic 
community associated with the invasive pinewood-boring wasp Sirex noctilio. 
Streptomyces sp. Sirex AA-E has shown that it secretes a full suite of endo- and exo-
cellulases, hemicellulases, pectinases and polysaccharide monooxygenases when 
grown on biomass. 
(Takasuka et al., 
2013) 




It produces antibiotics that inhibit the growth of other bacteria. (Gunnelius et 
al., 2014) 
Streptomyces cattleya 
NRRL 8057 = DSM 46488 
It produces the antibiotics thienamycin and cephamycin C and is one of the rare 
bacteria known to synthesise fluorinated metabolites. 
(Núñez et al., 
2003) 
Streptomyces pratensis It shows chemotaxonomic characteristics and also produces antibacterial 
compounds. 




It is a soil bacterium that produces milbemycins, a family of macrolide antibiotics 
that is commercially important in crop protection and veterinary medicine. This 
species has a huge number of protein-coding genes and a huge number of transport 
proteins, which form systems that are important for metabolism and also enable their 
adaptation to complex environments. 





It produces jingangmycin, an aminocyclitol antibiotic, which has been proven to be 
identical to validamycin. Jingangmycin has been widely used as a prime control 
reagent against sheath blight disease of rice plants and damping-off of cucumber 
seedlings in China and many other Eastern Asian countries. Meanwhile, its 
(Matsumoto et 
al., 1998) 
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transformed product, valienamine, is a pharmaceutically important precursor for the 




It produces antimycin A, which is widely used as a pesticide in the catfish farming 
industry and also has potent killing activity against insects, nematodes and fungi. 
(Baskaran et al., 
2014) 
Streptomyces venezuelae It produces chloromyeetin and jadomycin. (Pullan et al., 
2011) 
Streptomyces davawensis It produces the riboflavin analogs roseoflavin and 8-demethyl-8-amino-riboflavin. 
Both  compounds  show  antimicrobial  activity  against Gram-positive  bacteria  
such  as  Bacillus  subtilis,  but  also  against Gram-negative  bacteria  if  uptake  
systems  for  flavins/flavin  analogs are  present.  
(Jankowitsch et 
al., 2012) 
Streptomyces albus J1074 It is a widely used host for heterogenous expression of bioactive natural products. (Zaburannyi et 
al., 2014) 
Streptomyces albus DSM 
41398 
It produces salinomycin. Salinomycin has selective activity against cancer. 
However, it has been widely used as veterinary medicine in animal husbandry as 
food additive and growth promoter for years. 
(Yurkovich et 
al., 2012) 
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Streptomyces sp. PAMC 
26508 
This is an endosymbiotic bacterium isolated from the Antarctic lichen Cladonia 
borealis.  
(Kim et al., 
2014) 
Streptomyces fulvissimus It produces the ionophore antibiotic valinomycin. Secretes an antibacterial protein 
inhibitory to Micrococcus luteus, Bacillus subtillis, Bacillus cereus, and methicillin-
resistant Staphylococcus aureas strains.  
(Myronovskyi et 
al., 2013) 
Streptomyces collinus It produces ansatrienin A2, ansatrienin A3, ansatrienin B, napthomycin A, 
collinomycine, toromycin, streptocollin, kirromycin (elfamycin-family) and 
rubromycine. Causes common scab of potato. 
(Rückert et al., 
2013) 
Streptomyces 
rapamycinicus     
It produces produce rapamycin (also known as sirolimus) and azalomucin C, a 
macrodiolide antibiotic used as anthelmintic in animal fodder. Used as an 
immunosuppressant in renal transplant and for the prevention of restenosis after stent 
insertion for the treatment of coronary heart disease. 
(Baranasic et al., 
2013) 
Streptomyces albulus 
NK660     
It produces ε-Poly-L-lysine (ε-PL). ε-PL exhibits antimicrobial activity against a 
wide spectrum of microorganisms. Exhibits antiphage activity, and ε -PL has been 
used as a food preservative. 
(Gu et al., 2014) 
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Streptomyces albulus ZPM This species produces the homopolymer antibiotic, e-poly-lysine (e-PL). (Wang et al., 
2015b) 
Streptomyces lividans Used as a host for the synthesis and secretion of homologous and heterologous 
proteins of industrial interest. 
(Rückert et al., 
2015) 
Streptomyces glaucescens It produces tetracenomycin C, tetracenomycin D and tetracenomycin E.  Functions 




Thompson et al., 
2004) 
Streptomyces vietnamensis It forms a white aerial mycelium and a reddish brown substrate mycelium. It shows 
antibacterial activity against other bacterial species such as Escherichia coli, 
Pseudomonas aeruginosa, Candida albicans, Penicillium citrinum and B. subtilis.  
(Zhu et al., 
2007) 




It is a thermotolerant Streptomyces that produces nemadectin, which is a 
commercially important antibiotic. This is a macrolide antibiotic widely used as a 
(Wang et al., 
2015a) 
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biopesticide. It also produces chitosanase enzyme, which allows it to break down 
chitosan as a sole carbon source. 
Streptomyces sp. A02 This species produces antifungal metabolites. It is a producer of commercially 
important polyene macrocylic antibiotic natamycin and potential biocontrol agent to 
several plant fungal diseases. 
(Wu et al., 2015) 
Streptomyces xiamenensis It produces an anti-fibrotic benzopyran called xiamenmycin, a compound used for 
treating fibrotic diseases such as idiopathic pulmonary fibrosis, liver cirrhosis, 
progressive kidney disease, systemic sclerosis and cardiovascular fibrosis. 
(Xu et al., 2009) 
Streptomyces sp. Mg1 A Streptomyces producing a macrolide antibiotic called chalcomycin A, which takes 
part in inhibition of B. subtilis cell growth in combination by lysis and degradation 
of B. subtilis colonies. 
(Barger et al., 
2012, Hoefler et 
al., 2013) 
Streptomyces sp. CNQ-509 It contains 29 putative gene clusters used for biosynthesis of secondary metabolites, 
which are involved in the formation of meroterpenoid molecules. It produces a 
variety of terpenoid compounds. 
(Leipoldt et al., 
2015) 
Streptomyces ambofaciens It produces two antibiotics, namely spiramycin, which is a polyketide derivative, and 
congocidin (netropsin). Reports have indicated that it comprises 23 gene clusters, 
(Thibessard et 
al., 2015) 
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This Streptomyces produces two antibiotics, namely cyclohexadepsiptide 
pristinamycin (PI) and polyunsaturated macrolactone pristinamycin II (PII) co-
produced at a ratio of 30:70.  The PI plays a vital role in synergistic antibacterial 
activity of a wide range of gram-positive bacteria such as methicillin-resistant 
Staphylococci, drug-resistant Streptococcus pneumonia and vancomycin-resistant 
Enterococcus faecium and Gram negative bacteria such as Haemophilus sp. 
(Tian et al., 
2015) 
Streptomyces sp. CFMR 7 This species was discovered in rubber plantations in Penang Malaysia. It is has been 
found to degrade rubber. 
(Nanthini et al., 
2015) 
Streptomyces sp. CdTB01 It was isolated from soil contaminated with heavy metals. It can tolerate high 
concentrations of heavy metals such as cadmium. 
(Zhou et al., 
2016) 
Streptomyces reticuli It produces mycelia-associated cellulose, which can degrade crystalline cellulose to 
cellobiose. 
(Wibberg et al., 
2016) 
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Streptomyces sp. 4F Found in the soil in China, it is a fast grower and moderately thermophilic, i.e it 
grows at temperatures between 30oC and 50oC. It is therefore used for antibiotic 
expression and DNA assembly. 




It was isolated from the hyper-arid high-altitude Atacama Desert in Chile. It 
produces novel polyketide antibiotics such as the chaxamycins and chaxalactins. 
Chaxamycins A-D are ansamycin-type polyketides with potential antibacterial 
activity against MRSA. It is involved in anti-proliferative activity, which results 
from the inhibition of the ATPase activity of the human Hsp90 protein. 
(Gomez-




It has the potential to produce an anti-methicillin resistant Staphyloccocus aureus 
compound. 
(Kannan et al., 
2014) 
Streptomyces parvulus This streptomyces produces a polypeptide antibiotic called Actinomycin D, which is 
a potential anti-microbial agent against streptomycin-resistant pathogenic bacteria. 
(Shetty et al., 
2014) 
Streptomyces lydicus It produces actithiazic acid, streptolydigin, lydimycin, natamycin and 1-
deoxygalactonojirimycin. It has the ability to be used as an agent against fungal plant 
pathogens. It has also been reported that the species S. lydicus WYEC108 is a strong 
(Yuan and 
Crawford, 1995) 
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antagonist against various fungal plant root-rot and white-rot pathogens and a 
number of wood decay fungi.  
Streptomyces clavuligerus It produces more than 20 secondary metabolites, which include clavulanic acid that 
is a beta-lactam antibiotic. Clavulanic acid is a common antibiotic used in 
combination with β-lactam antibiotics (for example, Augmentin) to treat infections 
caused by β-lactamase-producing pathogens. It also synthesises the β-lactam 
antibiotic cephamycin C and numerous antifungal compounds with a clavam 
structure. 
(De la Fuente et 
al., 2002, 
Paradkar, 2013, 
Cao et al., 2016) 
Streptomyces 
griseochromogenes 
It produces blasticidin A, B, C, S. Blasticidin S is a potent antifungal and cytotoxic 
peptidyl nucleoside antibiotic. It also produces pentalenene and cytomycin. 
(Wu et al., 2017) 
Streptomyces lincolnensis It produces lincomycin, which is an anti-bacterial antibiotic. It also produces 
valienol, a C-7 cyclitol similar in structure to valienamine.  
(Peschke et al., 
1995) 
Streptomyces noursei It produces nystatin fungicidin, a polyene antifungal medication. (Brautaset et al., 
2000) 
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In contrast to the Streptomyces species, the mycobacterial species are well-known human pathogens, although there are some 
environmentally useful species in this genus. Table 2.4 below shows the importance of different mycobacterial species. 
Table 2. 4 General information on mycobacterial species. Mycobacterial species were grouped into six different categories following 
the criteria described elsewhere (Parvez et al., 2016). The six categories include Mycobacterium tuberculosis complex (MTBC), M. 
chelonae-abscessus complex (MCAC), M. avium complex (MAC), mycobacteria causing leprosy (MCL), nontuberculous mycobacteria 
(NTM) and saprophytes (SAP). The criteria for separation of mycobacterial species into six different groups is based on their 
characteristic features, including ecological niches, as well as the nature and site of infection as described elsewhere (Ventura et al., 
2007).  
Species name General information Reference 
Mycobacterium tuberculosis complex 
Mycobacterium africanum 
GM041182 
Causes TB in humans, especially in West African countries. (Bentley et al., 2012) 
Mycobacterium tuberculosis C Highly transmissible bacteria causing TB in humans. First isolated 
in New York City, USA and is highly transmitted among humans, 
causing TB. 
(Reddy et al., 2008) 
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Mycobacterium tuberculosis F11 Causes TB in humans. First isolated during a TB epidemic in the 
Western Cape of South Africa. 
(Victor et al., 2004) 
Mycobacterium tuberculosis H37Rv Best characterised and first genome sequenced strain causing TB in 
humans.  
(Cole et al., 1998) 
Mycobacterium tuberculosis H37Ra An avirulent strain derived from the H37Rv strain. This laboratory 
strain has since lost its virulence, and has different characteristics 
from its virulent sibling H37Rv, including decreased ability to 
survive in macrophages or hypoxic conditions, and loss of virulence 
in laboratory animals. 
(Brosch et al., 1999, 
Reddy et al., 2008) 
Mycobacterium tuberculosis 
Haarlem 
Human pathogen that causes TB. The first representative of the 
family was discovered in Haarlem, The Netherlands. 
(Brudey et al., 2006) 
Mycobacterium tuberculosis KZN 
1435 
Human pathogen that causes TB. It was first isolated in KwaZulu-
Natal, South Africa. 
(Ioerger et al., 2009) 
Mycobacterium tuberculosis KZN 
605 
Human pathogen that causes TB. It was first isolated in KwaZulu-
Natal, South Africa. 
(Ioerger et al., 2009) 
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Mycobacterium tuberculosis KZN 
4207 
Human pathogen that causes TB. It was first isolated in KwaZulu-
Natal, South Africa. 
(Ioerger et al., 2009) 
Mycobacterium tuberculosis 
RGTB327 
Human pathogen that causes TB. It was first isolated in Kerala, 
India.  




This strain shows 99% identity at DNA level with M. tuberculosis 
H37Rv but displays phenotypic differences. 
(Betts et al., 2000) 
Mycobacterium tuberculosis strains 
CCDC5079 
Human pathogen that causes TB. It was isolated in Fujian Province, 
China, in 2004. Sensitive to four first-line drugs. 
(Zhang et al., 2011a) 
Mycobacterium tuberculosis 
Beijing/NITR203 
Human pathogen that causes TB. It was first isolated in the Tamil 





Human pathogen that causes TB. It was first isolated in the Tamil 
Nadu state, India. 
(Narayanan and 
Deshpande, 2013) 
Mycobacterium tuberculosis EAI5 Human pathogen that causes TB. It was first isolatedin in Mumbai, 
India. 




Human pathogen that causes TB. It was first isolated in the Tamil 
Nadu state, India. 
(Narayanan and 
Deshpande, 2013) 
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Mycobacterium tuberculosis 
Erdman= ATCC 35801 
Isolated from human sputum by William H. Feldman in 1945, at 
Mayo Clinic, Rochester, MN, and deposited with the Trudeau 
Mycobacterium Culture Collection in 1946. It has been widely used 
as a standard virulent laboratory strain for virulence and 
immunisation studies. M. tuberculosis Erdman has a faster in vivo 
doubling time than two attenuated strains, M. tuberculosis H37Ra 
and Mycobacterium bovis Bacillus Calmette-Guerin (BCG), and a 




Mycobacterium tuberculosis UT205 Human pathogen that causes TB. It was isolated in Colombia. (Isaza et al., 2012) 
Mycobacterium canetii CIPT 
140010059 
Human pathogen that causes TB. However, it exhibits a smooth 
colony phenotype on culture media compared to M. tuberculosis 
H37Rv.  
(Supply et al., 2013) 
Mycobacterium canetii CIPT 
140060008 
Human pathogen that causes TB. However, it exhibits a smooth 
colony phenotype on culture media compared to M. tuberculosis 
H37Rv. 
(Supply et al., 2013) 
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Mycobacterium canetii CIPT 
140710010 
Human pathogen that causes TB. However, it exhibits a smooth 
colony phenotype on culture media compared to M. tuberculosis 
H37Rv. 
(Supply et al., 2013) 
Mycobacterium bovis AF 2122/97 It is the causative agent of TB in a range of animal species and man. 
M. bovis was also the progenitor for the M. bovis BCG vaccine
strain, the most widely used human vaccine. 
(Garnier et al., 2003) 
Mycobacterium bovis BCG Pasteur 
1173P2 
It is the causative agent of TB in cattle and other animals, including 
buffalo, lions and antelopes. The organism can also cause TB in 
humans. 
(Brosch et al., 2007) 
Mycobacterium bovis BCG Korea 
1168P 
Isolated in Korea. The strain that will actually be used in Korea for 
vaccine production. 
(Joung et al., 2013) 
Mycobacterium bovis BCG Mexico It was one of the most widely used sub-strains for vaccination in 
Mexico, BCG Mexico 1931.  
(Orduña et al., 2011) 
Mycobacterium bovis BCG Tokyo 
172 
Isolated in Tokyo, Japan. The strain used in Japan for vaccine 
production. 
(Seki et al., 2009) 
Mycobacterium chelonae-abscessus complex 
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Mycobacterium abscessus ATCC 
19977 
Rapidly growing mycobacterium. Causes a pseudotuberculous lung 
disease to patients with cystic fibrosis. Originally isolated from a 
human knee infection with subcutaneous abscess-like lesions in 
1953. 
(Ripoll et al., 2009) 
Mycobacterium abscessus subsp. 
bolletii 50594 
Rapidly growing mycobacterium. Causes nontuberculous 
mycobacterial infection. Isolated from a Korean patient with a 
pulmonary infection. 
(Kim et al., 2013) 
Mycobacterium avium complex 
Mycobacterium Avium 104 Opportunistic pathogen causes non-paratuberculosis. Isolated in 
Southern California, USA.  
(Horan et al., 2006) 
Mycobacterium Avium subsp. 
paratuberculosis K10 
The causative agent of Johne's disease in cattle and other ruminants. 
Clinically isolated from a dairy herd in Wisconsin in the mid-1970s. 
(Li et al., 2005) 
Mycobacterium avium subsp. 
paratuberculosis MAP4 
Etiologic agent of Johne's disease in ruminants. Associated with 
human Crohn's disease. Has a complex cell wall structure 
containing mycolic acids and several lipids, similar to those of other 
members of this genus, yet it is the most slowly growing member. 
(Bannantine et al., 
2014) 
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Originally isolated from the breast milk of a Crohn's disease patient 
in 2000. 
Mycobacterium intracellulare 
ATCC 13950  
Slow-growing mycobacteria responsible for opportunistic 
infections.  
(Kim et al., 2012c) 
Mycobacterium intracellulare 
MOTT-02 
Clinical isolate from Korean patients. Responsible for opportunistic 
infections (nontuberculous mycobacterial infection). 
(Kim et al., 2012b) 
Mycobacterium intracellulare 
MOTT-36Y 
Clinical isolate from Korean patients. Responsible for opportunistic 
infections (nontuberculous mycobacterial infection). 
(Kim et al., 2012a) 
Mycobacterium Indicus pranii 
MTCC 9506  
A saprophytic mycobacterial species that is known for its 
immunomodulatory properties in various human diseases. 
(Saini et al., 2012) 
Mycobacteria causing leprosy 
Mycobacterium leprae Br4923 Originally isolated from a leprosy patient in Brazil. Causes leprosy 
in humans.  
(Monot et al., 2009) 
Mycobacterium Leprae TN Isolated from an armadillo experimentally infected with M. leprae 
in biopsy material from a single lepromatous leprosy patient from 
Tamil Nadu, India. Human and animal pathogen.  
(Cole et al., 2001) 
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Nontuberculous mycobacteria 
Mycobacterium sp. JDM601 Causes TB-like disease in humans. (Zhang et al., 2011b) 
Mycobacterium liflandii 128FXT Amphibian pathogen. Originally isolated from infected Xenopus 
tropicalis at the University of California, Berkeley.  
(Tobias et al., 2013) 
Mycobacterium ulcerans Agy99 Human pathogen. Causes buruli ulcer. Isolated from an ulcerative 
lesion on the right elbow of a female patient from the Ga district of 
Ghana in 1999 
(Stinear et al., 2007) 
Mycobacterium Marinum M Ubiquitous pathogen of fish and amphibia. Shown to be a human 
pathogen as well. Facultative anaerobe. Unable to reduce nitrate and 
produces characteristic bright yellow carotenoid pigments when 
exposed to light. Isolated from a patient with fish tank granuloma in 
San Francisco in 1992. 
(Stinear et al., 2008) 
Saprophytes 
Mycobacterium sp. JLS This bacterium was isolated from soil in Libby, Montana, USA. 
This isolate belongs to a fast-growing group able to degrade high 
molecular weight PAH, including pyrene. 
(Chen et al., 2019) 
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Mycobacterium sp. KMS This bacterium was isolated from soil in Libby, Montana, USA. 
This isolate belongs to a fast-growing group able to degrade high 
molecular weight PAH, including pyrene. 
(Chen et al., 2019) 
Mycobacterium sp. MCS This bacterium was isolated from soil in Libby, Montana, USA. 
This isolate belongs to a fast-growing group able to degrade high 
molecular weight PAH, including pyrene. 
(Chen et al., 2019) 
Mycobacterium smegmatis 
MC2 155 
A nonpathogenic, fast-replicating mycobacterium that is widely 
used as a model system to study M. tuberculosis. 
(Mohan et al., 2015) 
Mycobacterium chubuense NBB4 Isolated on ethane as part of a bioprospecting study searching for 
novel monooxygenase enzymes. Strain NBB4 was shown to grow 
on C2–C4 alkenes and C2–C16 alkanes. 
(Coleman et al., 2011) 
Mycobacterium gilvum PYR-GCK Polycyclic aromatic hydrocarbons degradation and N-
Acetylnorfloxacin producing strain. 
(Badejo et al., 2013) 
Mycobacterium gilvum Spyr1  Mycobacterium sp. Spyr1 is a newly isolated strain that occurs in a 
creosote-contaminated site in Greece. It was isolated by an 
enrichment method using pyrene as sole carbon and energy source 
(Kallimanis et al., 
2011) 
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and is capable of degrading a wide range of PAH substrates 
including pyrene, fluoranthene, fluorene, anthracene and 
acenapthene. 
Mycobacterium sp. JS623 (formerly 
named as Mycobacterium 
smegmatis JS623) 
Model organism used in bioremediation studies. (Garcia and Gola, 
2016) 
Mycobacterium rhodesiae NBB3 Ethane and vinyl chloride-oxidising Mycobacterium strains of 
significance to bioremediation, biocatalysis and biogeochemistry. 
(Chen et al., 2019) 
Mycobacterium neoaurum VKM 
Ac-1815D 
Fast-growing soil mycobacteria. Used for efficient production of the 
key steroid intermediates (androst-4-ene-3,17-dione, androsta-1,4-
diene-3,17-dione, 9-hydroxy androst-4-ene-3,17-dione) from 
phytosterol. Originally isolated from soil samples. 
(Bragin et al., 2013) 
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2.6 Secondary metabolite biosynthetic gene clusters 
It is now well-established that genes involved in the synthesis of secondary metabolites form a 
cluster known as a biosynthetic gene cluster (BGC) (Medema et al., 2015). A BGC can be defined 
as a physically clustered group of two or more genes in a particular genome that together encode 
a biosynthetic pathway for the production of a specialised metabolite (including its chemical 
variants) (Medema et al., 2015). Quite a large number of BGCs were reported in bacteria, fungi 
and plants (Medema, 2018).  The availability of a large number of genome sequences enabled the 
development of novel tools to identify BGCs. A chronological order of tools developed for 
modelling BGCs, with genome information, is listed in Table 2.5. Using these programs, one can 
identity different types of secondary metabolite BGCs present in an organism. These programs 
also give the genes involved in synthesis of the particular secondary metabolite.  
© Central University of Technology, Free State
48 
Table 2. 5 Software programs available for predicting different secondary metabolite biosynthetic gene clusters (Weber et al., 2015). 
Software program Year of 
publication 
Main content and/or function Reference 
Model SEED 2010 First online high-throughput metabolic modeling tool (Henry et al., 2010) 
MEMOSys 2011 Allows management, storage and development of 
metabolic models 
(Pabinger et al., 2011) 
SuBliMinaL Toolbox 2011 Has strengths in managing chemical information for 
metabolites in a metabolic model 
(Swainston et al., 2011) 
FAME 2012 Allows streamlined analysis of a newly built metabolic 
model using various simulation methods 
(Boele et al., 2012) 
GEMSiRV 2012 Allows metabolic model reconstruction, simulation and 
visualisation 
(Liao et al., 2012) 
MetaFlux in Pathway 
Tools 
2012 Provides strong support for predicting, modelling, curating 
and visualising metabolic pathways 
(Latendresse et al., 2012) 
MicrobesFlux 2012 Allows both flux balance analysis (FBA) and dynamic 
FBA of a newly generated metabolic model 
(Feng et al., 2012) 
© Central University of Technology, Free State
49 
RAVEN Toolbox 2013 Allows metabolic model reconstruction, simulation and 
visualisation in MATLAB environment 
(Agren et al., 2013) 
CoReCo 2014 Useful for modelling metabolisms of multiple related 
species 
(Pitkanen et al., 2014) 
merlin 2015 Most recently released metabolic modelling program with 
comprehensive genome annotation functionalities 
necessary for model generation 
(Dias et al., 2015) 
antiSMASH 2015 Provides comprehensive genome mining platform for 
BGCs; currently the only platform offering automated 
modelling including secondary metabolite-specific 
reactions 
(Weber et al., 2015) 
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2.7. Cytochrome P450 monoxygenases 
2.7.1. Introduction 
Cytochrome P450 monooxygenases, also known as CYPs/P450s, are heme-thiolate proteins 
present in species belonging to all domains of life and even in non-living entities such as viruses 
(Nelson, 2018, Lamb et al., 2009). Cytochrome P450 (P450) enzymes have been studied for more 
than 50 years (Yamazaki, 2014). The origin of P450 enzymes has a historical perspective (Omura, 
2011). Two researchers, Garfinkel and Klingenberg, individually identified an enzyme that has a 
special absorption maximum wavelength of 450 nm as a carbon-monoxide binding pigment in the 
liver microsomes of rat and pig (Garfinkel, 1958, Klingenberg, 1958). Omura and co-workers then 
came up with the name ‘cytochrome P450’, which described the coloured substance that was found 
in a cell (Omura, 2011, Omura and Sato, 1962). This coloured substance produced an uncommon 
absorption peak at a wavelength of 450 nm when reduced and bound with carbon monoxide in rat 
liver microsomes (Figure 2.3) (Omura, 2011, Omura and Sato, 1962). There was a contradiction 
in the name ‘cytochrome’; some people called it an enzyme instead of a true cytochrome. The 
initial meaning of the term ‘cytochrome P450’ was ‘coloured substance in the cell’ (Omura and 
Sato, 1962). 
2.7.2. Nomenclature 
Standard nomenclature set by the International P450 Nomenclature Committee is followed for 
naming of P450s (Nelson, 1998, Nelson, 2006, Nelson et al., 1993). The rules of nomenclature are 
a CYP prefix, followed by an Arabic numeral, which designates family (all members nominally 
>40% identity), a capital letter designating the subfamily (all members nominally >55% identity), 
and an Arabic numeral designating the individual gene (all italics) or message and protein (no 
italics) (Figure 2.4) (Feyereisen, 2012). 
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Figure 2. 3 Typical cytochrome P450 monooxygenase ferrous-CO versus ferrous-difference 
spectrum (Guengerich et al., 2009). 
Figure 2. 4 Scheme of P450 nomenclature (Feyereisen, 2012). 
2.7.3. Catalytic diversity 
P450s were named after their initial reaction of monooxygenation, i.e. inserting one oxygen atom 
from water into substrate, as shown below: 
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RH   +   NAD (P) H   +    O2    +   P450      → ROH + H2O + NAD(P)H
The RH represents an organic substrate with P450 as the catalyst. The oxygen and NAD 
(P) (reduced nicotinamide adenine dinucleotide phosphate) and ROH constitute the hydroxylated
organic product. 
However, progress in characterisation of P450s over the years revealed that P450s are 
catalytically diverse and perform different enzymatic reactions apart from monooxygenation 
(Figure 2.5).  
Figure 2. 5 Reactions catalyzed by P450s (Lamb et al., 2007). 
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2.7.4. Role of P450s in secondary metabolite synthesis 
The secondary metabolite biosynthetic gene clusters comprise different genes. Among the genes, 
cytochrome P450 monooxygenases play a key role contributing to the chemical and structural 
diversity of secondary metabolites (Rudolf et al., 2017, Podust and Sherman, 2012, Greule et al., 
2018). In Mycobacterium tuberculosis H37Rv, P450s were found to be involved in synthesis of 
polyketides that play a role in virulence (Quadri, 2014). Quite a number of P450s were identified 
as part of biosynthetic gene clusters in Streptomyces species (Greule et al., 2018).  Table 2.6 
below shows the role of P450s in the synthesis of different groups of secondary metabolites.  
Table 2.6 Role of P450s in synthesis of different secondary metabolites (Greule et al., 2018). The 
oxygen incorporated as a result of this process is indicated in red.  
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Diterpene and steroid 
oxidation in bacterial 
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biodegradation. 
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diterpene is abietic 
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for steroids 
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P450 enzymes’ role 
in nonribosomal 
peptide synthesis. 
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CHAPTER 3: METHODOLOGY 
3.1. Species and database 
In total 60 Mycobacterial species and 48 Streptomyces species’ genomes available for public use 
from the Kyoto Encyclopedia of Genes and Genomes (KEGG) (Kanehisa et al., 2016) were used 
in this study (Table 3.1). Mycobacterial species and Streptomyces species used in this study, along 
with their names, species codes and individual genome IDs, were presented in Table 3.1. 
Table 3. 1 Information on mycobacterial species and Streptomyces species used in the study. 
Species names, codes, and genome IDs (from NCBI) were listed in the table. 
Species name Species code Genome ID 
Mycobacterial species 
Mycobacterium africanum GM041182 maf FR878060 
Mycobacterium tuberculosis C mto CP002992 
Mycobacterium tuberculosis F11 mtf CP000717 
Mycobacterium tuberculosis H37Ra mra CP000611 
Mycobacterium tuberculosis H37Rv mtu  NC_000962 
Mycobacterium tuberculosis Haarlem mtul  CP001664 
Mycobacterium tuberculosis KZN 1435 mtb  CP001658 
Mycobacterium tuberculosis KZN 605 mtz  CP001976 
Mycobacterium tuberculosis KZN 4207 mtk  CP001662 
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Mycobacterium  tuberculosis RGTB327 mtg  CP003233 
Mycobacterium tuberculosis CDC1551 mtc  AE000516 
Mycobacterium tuberculosis strains CCDC5079 mte  CP001641 
Mycobacterium tuberculosis 7199-99 mtub  HE663067 
Mycobacterium tuberculosis Beijing/NITR203 mtj  CP005082 
Mycobacterium tuberculosis CAS/NITR204 mtuc CP005386 
Mycobacterium tuberculosis EAI5 mtx CP006578 
Mycobacterium tuberculosis EAI5/NITR206 mtuh CP004886 
Mycobacterium tuberculosis Erdman=ATCC 35801 mtn  AP012340 
Mycobacterium tuberculosis UT205 mtd  HE608151 
Mycobacterium canetti CIPT 140010059 mce  HE572590 
Mycobacterium canetti CIPT 140060008 mcq  FO203507 
Mycobacterium canetti CIPT 140710010 mcx  FO203509 
Mycobacterium bovis AF 2122/97 mbo  NC_002945 
Mycobacterium bovis BCG Pasteur 1173P2 mbb  AM408590 
Mycobacterium bovis BCG Korea 1168P mbk CP003900 
Mycobacterium bovis BCG Mexico mbm CP002095 
Mycobacterium bovis BCG Toyko 172 mbt AP010918 
Mycobacterium abscessus ATCC 19977 mab  NC_010397 
Mycobacterium abscessus subsp.bolletti 50594 mabb  CP004374 
Mycobacterium abscessus 47J26 mabl  AP014547 
Mycobacterium abscessus 103 maz CP009408 
Mycobacterium abscessus subsp.bolletti MA 1948 may CP009408 
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Mycobacterium abscessus VO6705 mys CP009615 
Mycobacterium Avium 104 mav CP000479 
Mycobacterium Avium subsp.paratuberculosis K10 mpa AE016958 
Mycobacterium avium subsp.paratuberculosis 
MAP4 
mao  CP005928 
Mycobacterium intracellulare ATCC 13950 mia CP003322 
Mycobacterium intracellulare MOTT-02 mit  CP003323 
Mycobacterium intracellulare MOTT-64 mie  CP009499 
Mycobacterium intracellulare MOTT-36Y mmm  CP003491 
Mycobacterium indicus pranii MTCC 9506 mid CP002275 
Mycobacterium sp.JDM601 myv  CP009914 
Mycobacterium liflandi 128FXT mli CP003899 
Mycobacterium marinum mmae HG917972 
Mycobacterium massiliense mmal CP023147 
Mycobacterium kansassi ATCC 12478 mmv CP003699 
Mycobacterium vanbaalenii PYR-1 mva CP000511 
Mycobacterium smegmatis MC2 155 msb  CP009494 
Mycobacterium chubuense NBB4 mcb  CP003053 
Mycobacterium  gilvum PYR-GCK mgi  CP000656 
Mycobacterium gilvum Spyr1 msp  CP002385 
Mycobacterium smegmatis JS623 msa  CP003078 
Mycobacterium rhodesiae mrh  CP003169 
Mycobacterium neoaurum VKM Ac-18150 mne CP006936 




Streptomyces coelicolor sco  NC_003888  
Streptomyces avermitilis MA-4680 sma  BA000030 
Streptomyces griseus_NBRC_13350 sgr  AP009493 
Streptomyces globisporus sgb  CP013738 
Streptomyces scabiei 87.22 scb  FN554889 
Streptomyces sp. Sirex AA-E ssx CP002993 
Streptomyces violaceusniger Tu 4113 svl  CP002994 
Streptomyces cattleya NRRL 8057 sct FQ859185 
Streptomyces cattleya NRRL 8058 = DSM 46488 scy  CP003219 
Streptomyces pratensis/flavogriseus IAF 45 sfa  CP002475 
Streptomyces bingchenggensis sbh CP002047 
Streptomyces hygroscopicus subsp. jinggangensis 
5008 
shy  CP003275 
Streptomyces hygroscopicus subsp. jinggangensis 
TL01 
sho  CP003720 
Streptomyces venezuelae sve  FR845719 
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Streptomyces davawensis sdv HE971709 
Streptomyces albus J1074 salb  CP004370 
Streptomyces albus DSM 41398 sals  CP010519 
Streptomyces sp. PAMC 26508 strp  CP003990 
Streptomyces fulvissimus sfi  CP005080 
Streptomyces collinus sci  CP006259 
Streptomyces rapamycinicus          src CP006567 
Streptomyces albulus NK660      salu CP007574 
Streptomyces albus ZPM sall  CP006871 
Streptomyces lividans slv CP009124 
Streptomyces glaucescens sgu  CP009438 
Streptomyces vietnamensis svt  CP010407 
Streptomyces sp. 769 stre CP003987 
Streptomyces cyaneogriseus scw CP010849 
Streptomyces lydicus A02 sld  CP007699 
Streptomyces xiamenensis 318 sxi  CP009922 
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Streptomyces sp. Mg1 strm CP011664 
Streptomyces sp. CNQ-509 strc  CP011492 
Streptomyces ambofaciens samb   CP012382 
Streptomyces pristinaespiralis HCCB 10218 spri CP011340 
Streptomyces sp. CFMR 7 scz  CP011522 
Streptomyces sp. CdTB01 scx CP013743 
Streptomyces reticuli srw  LN997842 
Streptomyces sp. 4F strf  CP013142 
Streptomyces leeuwenhoekii C34(2013) sle  LN831790 
Streptomyces rubrolavendulae srn  CP017316 
Streptomyces parvulus spav  CP015866 
Streptomyces lydicus 103 slc CP017157 
Streptomyces sp. SAT1 strt CP015849 
Streptomyces clavuligerus sclf CP016559 
Streptomyces griseochromogenes sgs CP016279 
Streptomyces sp. S10(2016) stsi CP015098 
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Streptomyces lincolnensis sls  CP016438 
Streptomyces noursei snr CP011533 
3.2. Secondary metabolite biosynthetic gene clusters analysis 
Secondary metabolite BGCs analysis was carried out following the method described elsewhere 
(Mthethwa et al., 2018). Briefly, individual Streptomyces species’ and mycobacterial species’ 
genome IDs from NCBI (Table 3.1) were submitted to antibiotics and Secondary Metabolite 
Analysis Shell (anti-SMASH) (Weber et al., 2015) for identification of secondary metabolite 
BGCs. Results from anti-SMASH were downloaded both in the form of gene cluster sequences 
and Excel spreadsheets representing species-wise cluster information. Standard gene cluster 
abbreviation terminology available on the anti-SMASH database (Weber et al., 2015) was 
maintained in this study. 
3.3. Identification of P450s in biosynthetic gene clusters 
Individual gene-cluster sequences were manually checked for the presence of P450s. Once a P450 
had been identified, the sequence was selected and BLAST analysis was performed at the P450 
BLAST server (https://ksyed.weebly.com/p450-blast.html) to identify its name as annotated by the 
International P450 nomenclature committee (Nelson, 1998, Nelson, 2006). Based on the 
percentage identity to the named homolog P450, i.e. >40% amino acid identity and >55% amino 
acid identity, P450s were grouped under the same family and the same subfamily (Nelson, 1998, 
Nelson, 2006).  P450s that had less than 40% and 55% amino acid identity to the named homolog 
P450s were assigned to new P450 families and new P450 subfamilies. Some mycobacterial species 
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and Streptomyces species P450s were annotated and made available at the P450 BLAST server 
(https://ksyed.weebly.com/p450-blast.html). In this case, the same nomenclature for P450s was 
continued.  
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CHAPTER 4: RESULTS AND DISCUSSION 
4.1. Streptomyces species have a large and diverse number of secondary metabolite 
biosynthetic gene clusters 
Streptomyces species are well known for producing chemically diverse secondary metabolites 
(Hwang et al., 2014) Because of this ability one can expect the presence of a large number of 
secondary metabolite BGCs in Streptomyces species. As anticipated, genome-wide analysis 
revealed the presence of a large and diverse number of secondary metabolite BGCs in 
Streptomyces species compared to mycobacteria species (Figures 4.1-4.3). Almost double the 
number of secondary metabolite BGCs and eight times the types of BGCs were found in 48 
Streptomyces species compared to mycobacterial species (Figure 4.1). In total 1 461 secondary 
metabolite BGCs belonging to 159 types were found in 48 Streptomyces species compared to 898 
secondary metabolite BGCs belonging to only 18 types found in 60 mycobacterial species (Figure 
4.1). The average number of secondary metabolite BGCs was found to be double in Streptomyces 
species (30) compared to mycobacterial species (15) (Figure 4.2).  Among Streptomyces species, 
S. griseochromogenes has the highest number of secondary metabolite BGCs (49) and
Streptomyces sp. 4F has the lowest number of secondary metabolite BGCs (19) in their genomes 
(Figure 4.2A). M. marinum has the highest number of secondary metabolite BGCs (29) and two 
strains of M. leprae have the lowest number of secondary metabolite BGCs (five each) in their 
genomes (Figure 4.2B). Detailed information on secondary metabolite BGCs found in each of the 
species belonging to the genera Streptomyces and Mycobacterium is presented in Table 4.1. 




Figure 4. 1 Comparative analysis of key features of P450s between the genera Streptomyces and 
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Figure 4. 2 Comparative analysis of secondary metabolite BGCs and P450s associated with 
secondary metabolite BGCs in Streptomyces species (A) and mycobacterial species (B). Detailed 
information on secondary metabolite BGCs in Streptomyces species and mycobacterial species is 
presented in Table 4.1. 
Table 4. 1 Secondary metabolite biosynthetic gene clusters and P450 analysis in 48 Streptomyces 
species and 60 mycobacterial species. The number of P450s that formed part of each cluster and 
their corresponding P450 names (in parenthesis) were also presented in the table. Standard gene 
cluster abbreviation terminology available on the anti-SMASH database (Weber et al., 2015) was 
used in the table. 
Streptomyces species 
Streptomyces coelicolor










Leinamycin_biosynthetic_gene_cluster (2% of 
genes show similarity) 
BGC00011
01_c1 














Sanglifehrin_A_biosynthetic_gene_cluster (4% of 
genes show similarity) 
BGC00010
42_c1 




Coelichelin_biosynthetic_gene_cluster (100% of 
genes show similarity) 
BGC00003
25_c1 





of genes show similarity) 
BGC00005
18_c1 




Herboxidiene_biosynthetic_gene_cluster (8% of 








Ectoine_biosynthetic_gene_cluster (100% of 
genes show similarity) 
BGC00008
53_c1 




Lactonamycin_biosynthetic_gene_cluster (3% of 
genes show similarity) 
BGC00002
38_c1 
































































(100% of genes show similarity) 
BGC00010
63_c1 






















Enduracidin_biosynthetic_gene_cluster (8% of 












Coelimycin_biosynthetic_gene_cluster (100% of 









Nogalamycin_biosynthetic_gene_cluster (40% of 











SAL-2242_biosynthetic_gene_cluster (100% of 









Hopene_biosynthetic_gene_cluster (100% of 





































Ravidomycin_biosynthetic_gene_cluster (5% of 












Coelibactin_biosynthetic_gene_cluster (100% of 




Streptomyces avermitilis MA-4680 







SSV-2083_biosynthetic_gene_cluster (25% of 
genes show similarity) 
BGC00005
79_c1 




Filipin_biosynthetic_gene_cluster (100% of 









Herbimycin_biosynthetic_gene_cluster (13% of 











Landepoxcin_biosynthetic_gene_cluster (11% of 









Avermectin_biosynthetic_gene_cluster (100% of 








Carotenoid_biosynthetic_gene_cluster (100% of 
genes show similarity) 
BGC00006
33_c1 




Melanin_biosynthetic_gene_cluster (100% of 
genes show similarity) 
BGC00009
08_c1 




Daptomycin_biosynthetic_gene_cluster (7% of 



















Grincamycin_biosynthetic_gene_cluster (8% of 













































































Oligomycin_biosynthetic_gene_cluster (100% of 



































Meilingmycin_biosynthetic_gene_cluster (2% of 









Naphthomycin_biosynthetic_gene_cluster (9% of 











Herboxidiene_biosynthetic_gene_cluster (4% of 














WS9326_biosynthetic_gene_cluster (22% of 


























Melanin_biosynthetic_gene_cluster (100% of 











Pimaricin_biosynthetic_gene_cluster (11% of 









SCO-2138_biosynthetic_gene_cluster (50% of 









Ectoine_biosynthetic_gene_cluster (100% of 









Pristinamycin_biosynthetic_gene_cluster (2% of 









Herboxidiene_biosynthetic_gene_cluster (8% of 










Kirromycin_biosynthetic_gene_cluster (5% of 



















Herboxidiene_biosynthetic_gene_cluster (12% of 

















Cluster 1 Terpene 47111 72706 Isorenieratene_biosynthetic_gene_cluster (100% 














Daptomycin_biosynthetic_gene_cluster (7% of 








Tetronasin_biosynthetic_gene_cluster (11% of 
genes show similarity) 
BGC00001
63_c1 




Melanin_biosynthetic_gene_cluster (100% of 








Sporolide_biosynthetic_gene_cluster (53% of 










Tetronasin_biosynthetic_gene_cluster (3% of 
genes show similarity) 
BGC00001
63_c1 




SGR_PTMs_biosynthetic_gene_cluster (100% of 
genes show similarity) 
BGC00010
43_c1 
1 CYP107BX5  




Nucleocidin_biosynthetic_gene_cluster (47% of 
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Salinilactam_biosynthetic_gene_cluster (8% of 
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Grisemycin_biosynthetic_gene_cluster (100% of 









Herboxidiene_biosynthetic_gene_cluster (6% of 














Griseobactin_biosynthetic_gene_cluster (94% of 










Carotenoid_biosynthetic_gene_cluster (100% of 











Coelimycin_biosynthetic_gene_cluster (8% of 










of genes show similarity) 
BGC00006
64_c1 
Streptomyces globisporus C-1027 














Coelimycin_biosynthetic_gene_cluster (16% of 
genes show similarity) 
BGC00000
38_c1 











Griseobactin_biosynthetic_gene_cluster (100% of 
genes show similarity) 
BGC00003
68_c1 




Lasalocid_biosynthetic_gene_cluster (9% of 










Isorenieratene_biosynthetic_gene_cluster (85% of 
genes show similarity) 
BGC00006
64_c1 




Steffimycin_biosynthetic_gene_cluster (19% of 
genes show similarity) 
BGC00002
73_c1 




Ectoine_biosynthetic_gene_cluster (100% of 

















(100% of genes show similarity) 
BGC00009
41_c1 
















Oxazolomycin_biosynthetic_gene_cluster (6% of 





































Leinamycin_biosynthetic_gene_cluster (4% of 























Pristinamycin_biosynthetic_gene_cluster (23% of 
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Daptomycin_biosynthetic_gene_cluster (7% of 




Streptomyces scabiei 87.22 




Coelibactin_biosynthetic_gene_cluster (54% of 








Enduracidin_biosynthetic_gene_cluster (12% of 





























Carotenoid_biosynthetic_gene_cluster (63% of 






















Calcimycin_biosynthetic_gene_cluster (10% of 

















Grincamycin_biosynthetic_gene_cluster (8% of 










Medermycin_biosynthetic_gene_cluster (13% of 
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- -   











Thaxtomin_biosynthetic_gene_cluster (54% of 
























Herboxidiene_biosynthetic_gene_cluster (2% of 












































Melanin_biosynthetic_gene_cluster (100% of 













RK-682_biosynthetic_gene_cluster (45% of 
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Lasalocid_biosynthetic_gene_cluster (11% of 










Oxazolomycin_biosynthetic_gene_cluster (6% of 
































Scabichelin_biosynthetic_gene_cluster (100% of 










- -   
Streptomyces sp. SirexAA-E 




Thiocoraline_biosynthetic_gene_cluster (10% of 



















Melanin_biosynthetic_gene_cluster (100% of 








Coelichelin_biosynthetic_gene_cluster (100% of 








Coelibactin_biosynthetic_gene_cluster (100% of 








Steffimycin_biosynthetic_gene_cluster (19% of 








Ectoine_biosynthetic_gene_cluster (100% of 








Nataxazole_biosynthetic_gene_cluster (25% of 








Meilingmycin_biosynthetic_gene_cluster (2% of 





















Lactonamycin_biosynthetic_gene_cluster (3% of 





















- -   



































Hedamycin_biosynthetic_gene_cluster (15% of 


















Vicenistatin_biosynthetic_gene_cluster (60% of 











Leinamycin_biosynthetic_gene_cluster (2% of 





















SGR_PTMs_biosynthetic_gene_cluster (100% of 


















Streptomyces violaceusniger Tu 4113 















- -   




Echosides_biosynthetic_gene_cluster (100% of 








- -   
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Cluster 1 Butyrolacto
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(11% of genes show similarity) 
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Oxazolomycin_biosynthetic_gene_cluster (9% of 
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Streptomyces hygroscopicus subsp. jinggangensis 5008 




Validamycin_biosynthetic_gene_cluster (59% of 








Validamycin_biosynthetic_gene_cluster (18% of 
genes show similarity) 
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1 CYP105B22  




- -   
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- -   
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(57% of genes show similarity) 
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Streptomyces hygroscopicus subsp. jinggangensis TL01 




Validamycin_biosynthetic_gene_cluster (55% of 
genes show similarity) 
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22_c1 
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- -   




Avermectin_biosynthetic_gene_cluster (66% of 








- -   




Tetronasin_biosynthetic_gene_cluster (9% of 








- -   




Kanamycin_biosynthetic_gene_cluster (1% of 




























Goadsporin_biosynthetic_gene_cluster (12% of 












SAL-2242_biosynthetic_gene_cluster (100% of 










Scabichelin_biosynthetic_gene_cluster (40% of 










Herboxidiene_biosynthetic_gene_cluster (4% of 




























Ectoine_biosynthetic_gene_cluster (100% of 























Carotenoid_biosynthetic_gene_cluster (54% of 










Herboxidiene_biosynthetic_gene_cluster (12% of 
genes show similarity) 
BGC00010
65_c1 










Candicidin_biosynthetic_gene_cluster (100% of 




Streptomyces albus DSM 41398 




Incednine_biosynthetic_gene_cluster (9% of 




















Salinomycin_biosynthetic_gene_cluster (100% of 








Pyralomicin_biosynthetic_gene_cluster (22% of 






















- -   




Oligomycin_biosynthetic_gene_cluster (55% of 















Lasalocid_biosynthetic_gene_cluster (20% of 













Isorenieratene_biosynthetic_gene_cluster (85% of 


























Arginomycin_biosynthetic_gene_cluster (20% of 



















































Istamycin_biosynthetic_gene_cluster (4% of 























Albachelin_biosynthetic_gene_cluster (70% of 










Herboxidiene_biosynthetic_gene_cluster (2% of 









Stenothricin_biosynthetic_gene_cluster (13% of 























SAL-2242_biosynthetic_gene_cluster (100% of 
























Kinamycin_biosynthetic_gene_cluster (48% of 




























Salinilactam_biosynthetic_gene_cluster (8% of 









Ectoine_biosynthetic_gene_cluster (100% of 














































Elaiophylin_biosynthetic_gene_cluster (79% of 
genes show similarity) 
BGC00000
53_c1 












Zorbamycin_biosynthetic_gene_cluster (6% of 












of genes show similarity) 
BGC00002
71_c1 




Melanin_biosynthetic_gene_cluster (100% of 








Tetronasin_biosynthetic_gene_cluster (11% of 
genes show similarity) 
BGC00001
63_c1 











Ectoine_biosynthetic_gene_cluster (100% of 
genes show similarity) 
BGC00008
53_c1 




Steffimycin_biosynthetic_gene_cluster (19% of 









Cinerubin_B_biosynthetic_gene_cluster (28% of 









Ectoine_biosynthetic_gene_cluster (100% of 
genes show similarity) 
BGC00008
53_c1 




































Istamycin_biosynthetic_gene_cluster (11% of 














Lactonamycin_biosynthetic_gene_cluster (3% of 































Arylomycin_biosynthetic_gene_cluster (22% of 

















Vicenistatin_biosynthetic_gene_cluster (60% of 

































BE-14106_biosynthetic_gene_cluster (10% of 


































Coelichelin_biosynthetic_gene_cluster (90% of 



















Cluster 1 Terpene 24365 49959 Isorenieratene_biosynthetic_gene_cluster (100% 








A-500359s_biosynthetic_gene_cluster (5% of 















Coelimycin_biosynthetic_gene_cluster (16% of 

















Griseobactin_biosynthetic_gene_cluster (94% of 








Coelichelin_biosynthetic_gene_cluster (81% of 

















Herboxidiene_biosynthetic_gene_cluster (6% of 
genes show similarity) 
BGC00010
65_c1 







Steffimycin_biosynthetic_gene_cluster (19% of 










Ectoine_biosynthetic_gene_cluster (100% of 








































































































Calcimycin_biosynthetic_gene_cluster (17% of 


















Nataxazole_biosynthetic_gene_cluster (7% of 









Lomofungin_biosynthetic_gene_cluster (13% of 
















Salinomycin_biosynthetic_gene_cluster (14% of 











Hexaricin_biosynthetic_gene_cluster (6% of 









Nonactin_biosynthetic_gene_cluster (92% of 



















SGR_PTMs_biosynthetic_gene_cluster (100% of 










Tetronasin_biosynthetic_gene_cluster (3% of 









Valinomycin_biosynthetic_gene_cluster (22% of 









Melanin_biosynthetic_gene_cluster (100% of 





















Streptocollin_biosynthetic_gene_cluster (100% of 









Azicemicin_biosynthetic_gene_cluster (11% of 









Kirromycin_biosynthetic_gene_cluster (81% of 










of genes show similarity) 
BGC00012
27_c1 




Lasalocid_biosynthetic_gene_cluster (11% of 









Melanin_biosynthetic_gene_cluster (71% of 
genes show similarity) 
BGC00009
08_c1 




Piericidin_A1_biosynthetic_gene_cluster (16% of 
genes show similarity) 
BGC00001
24_c1 




- - 2 CYP1059A1; 
CYP105B21 




Stenothricin_biosynthetic_gene_cluster (13% of 









Herboxidiene_biosynthetic_gene_cluster (6% of 












Cinnamycin_biosynthetic_gene_cluster (14% of 









Ectoine_biosynthetic_gene_cluster (100% of 












r (25% of genes show similarity) 
BGC00002
68_c1 











Istamycin_biosynthetic_gene_cluster (5% of 
































Chalcomycin_biosynthetic_gene_cluster (7% of 

































































Tetronasin_biosynthetic_gene_cluster (3% of 

































(58% of genes show similarity) 
BGC00006
53_c1 


















A-503083_biosynthetic_gene_cluster (7% of 













of genes show similarity) 
BGC00005
18_c1 









Kirromycin_biosynthetic_gene_cluster (81% of 















Streptocollin_biosynthetic_gene_cluster (100% of 









Lobophorin_biosynthetic_gene_cluster (36% of 








Coelichelin_biosynthetic_gene_cluster (90% of 










- -   




ECO-02301_biosynthetic_gene_cluster (39% of 








Nigericin_biosynthetic_gene_cluster (100% of 








Salinomycin_biosynthetic_gene_cluster (8% of 








Elaiophylin_biosynthetic_gene_cluster (87% of 








Daptomycin_biosynthetic_gene_cluster (4% of 










Meilingmycin_biosynthetic_gene_cluster (2% of 










Meilingmycin_biosynthetic_gene_cluster (4% of 










Feglymycin_biosynthetic_gene_cluster (78% of 













Neocarzilin_biosynthetic_gene_cluster (57% of 














BE-7585A_biosynthetic_gene_cluster (23% of 












Streptomycin_biosynthetic_gene_cluster (4% of 














































Echosides_biosynthetic_gene_cluster (100% of 





















TP-1161_biosynthetic_gene_cluster (41% of 





















Skyllamycin_biosynthetic_gene_cluster (44% of 












7-prenylisatin_biosynthetic_gene_cluster (40% of 

























WS9326_biosynthetic_gene_cluster (25% of 










ECO-02301_biosynthetic_gene_cluster (57% of 


















Ectoine_biosynthetic_gene_cluster (100% of 












Apoptolidin_biosynthetic_gene_cluster (23% of 










Xiamycin_biosynthetic_gene_cluster (26% of 










Oligomycin_biosynthetic_gene_cluster (50% of 























Rapamycin_biosynthetic_gene_cluster (96% of 












Galbonolides_biosynthetic_gene_cluster (20% of 
































Skyllamycin_biosynthetic_gene_cluster (18% of 










Meridamycin_biosynthetic_gene_cluster (73% of 










Hygrocin_biosynthetic_gene_cluster (90% of 


















Bafilomycin_biosynthetic_gene_cluster (50% of 



















Herboxidiene_biosynthetic_gene_cluster (4% of 







































Carotenoid_biosynthetic_gene_cluster (63% of 











Chalcomycin_biosynthetic_gene_cluster (7% of 








Ansamitocin_biosynthetic_gene_cluster (12% of 








Guadinomine_biosynthetic_gene_cluster (7% of 








Sporolide_biosynthetic_gene_cluster (8% of 








Stenothricin_biosynthetic_gene_cluster (13% of 















Himastatin_biosynthetic_gene_cluster (8% of 








Siomycin_biosynthetic_gene_cluster (7% of 

































Nystatin_biosynthetic_gene_cluster (81% of 

































Streptomycin_biosynthetic_gene_cluster (8% of 





















Ectoine_biosynthetic_gene_cluster (100% of 










Salinomycin_biosynthetic_gene_cluster (6% of 




































Svaricin_biosynthetic_gene_cluster (15% of 























Rabelomycin_biosynthetic_gene_cluster (39% of 



























Oxazolomycin_biosynthetic_gene_cluster (9% of 











Coelimycin_biosynthetic_gene_cluster (8% of 










Azicemicin_biosynthetic_gene_cluster (11% of 











SAL-2242_biosynthetic_gene_cluster (100% of 












Lactonamycin_biosynthetic_gene_cluster (7% of 









Stenothricin_biosynthetic_gene_cluster (13% of 











Nystatin_biosynthetic_gene_cluster (81% of 











Kedarcidin_biosynthetic_gene_cluster (4% of 






















Streptomyces albus ZPM 
Cluster 1 Nrps 17026 10975
3 
Himastatin_biosynthetic_gene_cluster (24% of 












Chalcomycin_biosynthetic_gene_cluster (7% of 








Guadinomine_biosynthetic_gene_cluster (7% of 








Sporolide_biosynthetic_gene_cluster (8% of 
genes show similarity) 
BGC00001
50_c1 




Stenothricin_biosynthetic_gene_cluster (13% of 
genes show similarity) 
BGC00004
31_c1 




Tetarimycin_biosynthetic_gene_cluster (5% of 












Himastatin_biosynthetic_gene_cluster (8% of 
genes show similarity) 
BGC00011
17_c1 




Hygrocin_biosynthetic_gene_cluster (6% of 
































Rimocidin_biosynthetic_gene_cluster (63% of 












































Ectoine_biosynthetic_gene_cluster (100% of 









Salinomycin_biosynthetic_gene_cluster (6% of 









Meridamycin_biosynthetic_gene_cluster (5% of 
































































Rabelomycin_biosynthetic_gene_cluster (39% of 























Oxazolomycin_biosynthetic_gene_cluster (9% of 











Coelimycin_biosynthetic_gene_cluster (8% of 










Azicemicin_biosynthetic_gene_cluster (13% of 
























Lactonamycin_biosynthetic_gene_cluster (7% of 









Stenothricin_biosynthetic_gene_cluster (13% of 









Nystatin_biosynthetic_gene_cluster (50% of 





















Toxoflavin_biosynthetic_gene_cluster (50% of 





















Himastatin_biosynthetic_gene_cluster (24% of 


















Coelibactin_biosynthetic_gene_cluster (100% of 








Ravidomycin_biosynthetic_gene_cluster (5% of 
genes show similarity) 
BGC00002
63_c1 



























Nogalamycin_biosynthetic_gene_cluster (40% of 









Coelimycin_biosynthetic_gene_cluster (100% of 
genes show similarity) 
BGC00000
38_c1 




Enduracidin_biosynthetic_gene_cluster (8% of 









Herboxidiene_biosynthetic_gene_cluster (2% of 



























































































Lactonamycin_biosynthetic_gene_cluster (3% of 










Ectoine_biosynthetic_gene_cluster (100% of 










Herboxidiene_biosynthetic_gene_cluster (8% of 





















Coelichelin_biosynthetic_gene_cluster (100% of 












Sanglifehrin_A_biosynthetic_gene_cluster (4% of 























Leinamycin_biosynthetic_gene_cluster (2% of 




















Lactazole_biosynthetic_gene_cluster (55% of 








Acarviostatin_biosynthetic_gene_cluster (37% of 


















Carotenoid_biosynthetic_gene_cluster (63% of 








Melanin_biosynthetic_gene_cluster (57% of 








SW-163_biosynthetic_gene_cluster (32% of 








BE-14106_biosynthetic_gene_cluster (17% of 










Xantholipin_biosynthetic_gene_cluster (6% of 








Ectoine_biosynthetic_gene_cluster (100% of 










Melanin_biosynthetic_gene_cluster (80% of 


















































Coelimycin_biosynthetic_gene_cluster (8% of 



































Grincamycin_biosynthetic_gene_cluster (5% of 






























































Zorbamycin_biosynthetic_gene_cluster (8% of 











Venezuelin_biosynthetic_gene_cluster (75% of 

















Ectoine_biosynthetic_gene_cluster (100% of 















Coelimycin_biosynthetic_gene_cluster (8% of 











Lankamycin_biosynthetic_gene_cluster (26% of 








Lomofungin_biosynthetic_gene_cluster (13% of 








- -   















Granaticin_biosynthetic_gene_cluster (64% of 





















Istamycin_biosynthetic_gene_cluster (8% of 










Stambomycin_biosynthetic_gene_cluster (16% of 




























Kinamycin_biosynthetic_gene_cluster (51% of 


















































Enduracidin_biosynthetic_gene_cluster (14% of 










Griseobactin_biosynthetic_gene_cluster (11% of 





































































Coelimycin_biosynthetic_gene_cluster (29% of 











Ansamitocin_biosynthetic_gene_cluster (14% of 





















A-503083_biosynthetic_gene_cluster (7% of 








- -   




- - 1 CYP157C31 




Nystatin_biosynthetic_gene_cluster (100% of 











Coelimycin_biosynthetic_gene_cluster (8% of 
genes show similarity) 
BGC00000
38_c1 


















































Desotamide_biosynthetic_gene_cluster (63% of 

















Albonoursin_biosynthetic_gene_cluster (83% of 










Aldgamycin_biosynthetic_gene_cluster (47% of 



















Legonaridin_biosynthetic_gene_cluster (55% of 










Salinomycin_biosynthetic_gene_cluster (6% of 












Melanin_biosynthetic_gene_cluster (40% of 










Ectoine_biosynthetic_gene_cluster (100% of 




































Streptomycin_biosynthetic_gene_cluster (16% of 







































Zorbamycin_biosynthetic_gene_cluster (6% of 








































Hygrocin_biosynthetic_gene_cluster (6% of 













Friulimicin_biosynthetic_gene_cluster (9% of 





















Zorbamycin_biosynthetic_gene_cluster (8% of 













Natamycin_biosynthetic_gene_cluster (68% of 













Coelimycin_biosynthetic_gene_cluster (29% of 









Pristinamycin_biosynthetic_gene_cluster (7% of 









Carotenoid_biosynthetic_gene_cluster (45% of 



















Tautomycin_biosynthetic_gene_cluster (27% of 








Azicemicin_biosynthetic_gene_cluster (8% of 








BE-14106_biosynthetic_gene_cluster (17% of 








Kirromycin_biosynthetic_gene_cluster (3% of 








Ectoine_biosynthetic_gene_cluster (100% of 










Lactonamycin_biosynthetic_gene_cluster (3% of 










Melanin_biosynthetic_gene_cluster (60% of 























TP-1161_biosynthetic_gene_cluster (20% of 





















Oligomycin_biosynthetic_gene_cluster (44% of 



































Herboxidiene_biosynthetic_gene_cluster (2% of 















































Isorenieratene_biosynthetic_gene_cluster (18% of 












Reveromycin_biosynthetic_gene_cluster (9% of 












Taromycin_biosynthetic_gene_cluster (26% of 










- - 1 CYP157K4 


















Enterocin_biosynthetic_gene_cluster (55% of 
















Streptomyces lydicus A02 
Cluster 1 T2pks 1 36695 Xantholipin_biosynthetic_gene_cluster (46% of 










































Meilingmycin_biosynthetic_gene_cluster (3% of 









(11% of genes show similarity) 
BGC00008
93_c1 




Streptomycin_biosynthetic_gene_cluster (4% of 








Frankiamicin_biosynthetic_gene_cluster (21% of 






























Siomycin_biosynthetic_gene_cluster (11% of 













BE-14106_biosynthetic_gene_cluster (10% of 









Kanamycin_biosynthetic_gene_cluster (7% of 

























Enduracidin_biosynthetic_gene_cluster (16% of 




























Salinomycin_biosynthetic_gene_cluster (6% of 


















Chaxapeptin_biosynthetic_gene_cluster (42% of 


















Ectoine_biosynthetic_gene_cluster (100% of 



















ECO-02301_biosynthetic_gene_cluster (46% of 












Grincamycin_biosynthetic_gene_cluster (58% of 










Scabichelin_biosynthetic_gene_cluster (20% of 












Herbimycin_biosynthetic_gene_cluster (10% of 











Streptomycin_biosynthetic_gene_cluster (2% of 













Friulimicin_biosynthetic_gene_cluster (12% of 




















Natamycin_biosynthetic_gene_cluster (100% of 




















SAL-2242_biosynthetic_gene_cluster (60% of 

























of genes show similarity) 
BGC00009
33_c1 





(60% of genes show similarity) 
BGC00009
41_c1 




Ectoine_biosynthetic_gene_cluster (100% of 
genes show similarity) 
BGC00008
53_c1 









































of genes show similarity) 
BGC00009
14_c1 




Lomaiviticin_biosynthetic_gene_cluster (38% of 























































Valinomycin_biosynthetic_gene_cluster (16% of 









Carotenoid_biosynthetic_gene_cluster (18% of 






















Herboxidiene_biosynthetic_gene_cluster (7% of 










Akaeolide_biosynthetic_gene_cluster (12% of 









WS9326_biosynthetic_gene_cluster (15% of 
genes show similarity) 
BGC00012
97_c1 
Streptomyces sp. Mg1 




Isorenieratene_biosynthetic_gene_cluster (85% of 
genes show similarity) 
BGC00006
64_c1 




Maklamicin_biosynthetic_gene_cluster (6% of 









Xantholipin_biosynthetic_gene_cluster (4% of 










- - 2 CYP157C26; 
CYP134A3 
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Divergolide_biosynthetic_gene_cluster (13% of 

















ECO-02301_biosynthetic_gene_cluster (75% of 








Thaxtomin_biosynthetic_gene_cluster (18% of 













































Meilingmycin_biosynthetic_gene_cluster (2% of 



















































Aldgamycin_biosynthetic_gene_cluster (44% of 
























Herboxidiene_biosynthetic_gene_cluster (3% of 






























- - 1 CYP251F1 








Tetronomycin_biosynthetic_gene_cluster (90% of 








Laspartomycin_biosynthetic_gene_cluster (6% of 








Taromycin_biosynthetic_gene_cluster (6% of 









Ectoine_biosynthetic_gene_cluster (100% of 








- -   




Arginomycin_biosynthetic_gene_cluster (6% of 

















- -   




Sporolide_biosynthetic_gene_cluster (6% of 









































Pactamycin_biosynthetic_gene_cluster (3% of 










- - 1 CYP1341E2 















Pactamycin_biosynthetic_gene_cluster (11% of 











Laspartomycin_biosynthetic_gene_cluster (9% of 












Merochlorin_biosynthetic_gene_cluster (26% of 










Isorenieratene_biosynthetic_gene_cluster (85% of 



























Fluostatin_biosynthetic_gene_cluster (35% of 



















A47934_biosynthetic_gene_cluster (50% of 



















































Fluostatin_biosynthetic_gene_cluster (29% of 











Antimycin_biosynthetic_gene_cluster (100% of 
genes show similarity) 
BGC00009
58_c1 




- - 1 CYP156B15 




Carotenoid_biosynthetic_gene_cluster (27% of 
genes show similarity) 
BGC00006
33_c1 




Ectoine_biosynthetic_gene_cluster (100% of 
genes show similarity) 
BGC00008
53_c1 




Melanin_biosynthetic_gene_cluster (60% of 
genes show similarity) 
BGC00009
09_c1 



















Zorbamycin_biosynthetic_gene_cluster (6% of 








































Midecamycin_biosynthetic_gene_cluster (41% of 


















Herboxidiene_biosynthetic_gene_cluster (2% of 









Grincamycin_biosynthetic_gene_cluster (8% of 






















Congocidine_biosynthetic_gene_cluster (100% of 




























Coelichelin_biosynthetic_gene_cluster (100% of 










Isorenieratene_biosynthetic_gene_cluster (57% of 
























Tetronasin_biosynthetic_gene_cluster (5% of 










Clavams_biosynthetic_gene_cluster (18% of 













Fluostatin_biosynthetic_gene_cluster (29% of 
















Pristinamycin_biosynthetic_gene_cluster (93% of 










Lasalocid_biosynthetic_gene_cluster (11% of 










Albachelin_biosynthetic_gene_cluster (80% of 



















Kanamycin_biosynthetic_gene_cluster (1% of 
























Isorenieratene_biosynthetic_gene_cluster (85% of 




























Melanin_biosynthetic_gene_cluster (100% of 









































Ectoine_biosynthetic_gene_cluster (100% of 







































Pristinamycin_biosynthetic_gene_cluster (97% of 






























Kosinostatin_biosynthetic_gene_cluster (9% of 










Daptomycin_biosynthetic_gene_cluster (7% of 
genes show similarity) 
BGC00003
36_c1 





of genes show similarity) 
BGC00006
64_c1 




Herboxidiene_biosynthetic_gene_cluster (12% of 
genes show similarity) 
BGC00010
65_c1 




Melanin_biosynthetic_gene_cluster (100% of 








Valinomycin_biosynthetic_gene_cluster (22% of 
genes show similarity) 
BGC00004
53_c1 




Tallysomycin_biosynthetic_gene_cluster (7% of 









SGR_PTMs_biosynthetic_gene_cluster (100% of 








Bafilomycin_biosynthetic_gene_cluster (100% of 
genes show similarity) 
BGC00000
28_c1 

























Asukamycin_biosynthetic_gene_cluster (11% of 











































Neocarzilin_biosynthetic_gene_cluster (21% of 

















































Rabelomycin_biosynthetic_gene_cluster (25% of 












Skyllamycin_biosynthetic_gene_cluster (8% of 





































































Ectoine_biosynthetic_gene_cluster (100% of 









Steffimycin_biosynthetic_gene_cluster (19% of 
genes show similarity) 
BGC00002
73_c1 









Herboxidiene_biosynthetic_gene_cluster (6% of 



















Coelichelin_biosynthetic_gene_cluster (81% of 














Griseobactin_biosynthetic_gene_cluster (94% of 



















Coelimycin_biosynthetic_gene_cluster (16% of 












A-500359s_biosynthetic_gene_cluster (5% of 




Streptomyces sp. CdTB01 




Friulimicin_biosynthetic_gene_cluster (21% of 








Lomaiviticin_biosynthetic_gene_cluster (35% of 








Herboxidiene_biosynthetic_gene_cluster (3% of 








Azicemicin_biosynthetic_gene_cluster (11% of 













































Grincamycin_biosynthetic_gene_cluster (8% of 
























































































Gilvocarcin_biosynthetic_gene_cluster (7% of 












Pactamycin_biosynthetic_gene_cluster (5% of 













Chaxapeptin_biosynthetic_gene_cluster (42% of 





















Melanin_biosynthetic_gene_cluster (100% of 










Ectoine_biosynthetic_gene_cluster (100% of 



















Pradimicin_biosynthetic_gene_cluster (7% of 











Maduropeptin_biosynthetic_gene_cluster (3% of 









Melanin_biosynthetic_gene_cluster (57% of 









Carotenoid_biosynthetic_gene_cluster (63% of 











Antimycin_biosynthetic_gene_cluster (100% of 









ECO-02301_biosynthetic_gene_cluster (7% of 











Merochlorin_biosynthetic_gene_cluster (4% of 




Cluster 1 T1pks 58809 16939
3 
Naphthomycin_biosynthetic_gene_cluster (71% 



















Tambromycin_biosynthetic_gene_cluster (14% of 








Carotenoid_biosynthetic_gene_cluster (54% of 
genes show similarity) 
BGC00006
33_c1 




Kanamycin_biosynthetic_gene_cluster (1% of 









Melanin_biosynthetic_gene_cluster (57% of 





















Hedamycin_biosynthetic_gene_cluster (31% of 










Herboxidiene_biosynthetic_gene_cluster (8% of 

























Chaxapeptin_biosynthetic_gene_cluster (42% of 









Ectoine_biosynthetic_gene_cluster (100% of 



















Laspartomycin_biosynthetic_gene_cluster (6% of 











Istamycin_biosynthetic_gene_cluster (5% of 
























Pyralomicin_biosynthetic_gene_cluster (14% of 




























Friulimicin_biosynthetic_gene_cluster (30% of 












Meilingmycin_biosynthetic_gene_cluster (6% of 












































Rifamycin_biosynthetic_gene_cluster (3% of 
genes show similarity) 
BGC00001
36_c1 

















Antimycin_biosynthetic_gene_cluster (100% of 
















(100% of genes show similarity) 
BGC00002
82_c1 




Carotenoid_biosynthetic_gene_cluster (54% of 
genes show similarity) 
BGC00006
33_c1 





of genes show similarity) 
BGC00002
71_c1 




Ectoine_biosynthetic_gene_cluster (100% of 
genes show similarity) 
BGC00008
53_c1 




SCO-2138_biosynthetic_gene_cluster (64% of 
genes show similarity) 
BGC00005
95_c1 

























Friulimicin_biosynthetic_gene_cluster (18% of 
















Herboxidiene_biosynthetic_gene_cluster (3% of 









Althiomycin_biosynthetic_gene_cluster (66% of 









Grincamycin_biosynthetic_gene_cluster (11% of 































Hedamycin_biosynthetic_gene_cluster (34% of 













Streptomyces leeuwenhoekii C34(2013) 
Cluster 1 T1pks 99264 14343
0 








Cremimycin_biosynthetic_gene_cluster (15% of 









Pristinamycin_biosynthetic_gene_cluster (12% of 











of genes show similarity) 
BGC00005
18_c1 





















Rishirilide_B_biosynthetic_gene_cluster (7% of 















Leinamycin_biosynthetic_gene_cluster (18% of 
















































Grincamycin_biosynthetic_gene_cluster (8% of 











Herboxidiene_biosynthetic_gene_cluster (2% of 



































Herboxidiene_biosynthetic_gene_cluster (3% of 























TP-1161_biosynthetic_gene_cluster (20% of 










Arginomycin_biosynthetic_gene_cluster (10% of 





















Melanin_biosynthetic_gene_cluster (100% of 













Neocarzilin_biosynthetic_gene_cluster (21% of 










Ectoine_biosynthetic_gene_cluster (100% of 










Kirromycin_biosynthetic_gene_cluster (3% of 










BE-14106_biosynthetic_gene_cluster (17% of 










Brasilinolide_biosynthetic_gene_cluster (4% of 










JBIR-100_biosynthetic_gene_cluster (66% of 










Herbimycin_biosynthetic_gene_cluster (10% of 
genes show similarity) 
BGC00000
74_c1 




















Carotenoid_biosynthetic_gene_cluster (54% of 









- -   




- - 3 CYP251A3; 
CYP157C21; 
CYP158A20 




Desotamide_biosynthetic_gene_cluster (9% of 










Akaeolide_biosynthetic_gene_cluster (12% of 








Staurosporine_biosynthetic_gene_cluster (60% of 











- -   
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Ectoine_biosynthetic_gene_cluster (100% of 

















Istamycin_biosynthetic_gene_cluster (11% of 

















Viomycin_biosynthetic_gene_cluster (95% of 











Bleomycin_biosynthetic_gene_cluster (9% of 










Cyclooctatin_biosynthetic_gene_cluster (100% of 








































Kanamycin_biosynthetic_gene_cluster (2% of 
































Neomycin_biosynthetic_gene_cluster (63% of 










Herbimycin_biosynthetic_gene_cluster (6% of 






















Lomofungin_biosynthetic_gene_cluster (26% of 










Daptomycin_biosynthetic_gene_cluster (7% of 






Cluster 1 Terpene 90078 11113
6 
2-methylisoborneol_biosynthetic_gene_cluster 

















Ravidomycin_biosynthetic_gene_cluster (5% of 









Actinomycin_biosynthetic_gene_cluster (82% of 








Ectoine_biosynthetic_gene_cluster (100% of 








Melanin_biosynthetic_gene_cluster (60% of 

















Borrelidin_biosynthetic_gene_cluster (4% of 
























































Herboxidiene_biosynthetic_gene_cluster (2% of 













Grincamycin_biosynthetic_gene_cluster (8% of 












SAL-2242_biosynthetic_gene_cluster (100% of 





















Versipelostatin_biosynthetic_gene_cluster (5% of 






















Coelichelin_biosynthetic_gene_cluster (90% of 










Kanamycin_biosynthetic_gene_cluster (1% of 











Svaricin_biosynthetic_gene_cluster (12% of 








Laspartomycin_biosynthetic_gene_cluster (4% of 



















- -   




Ectoine_biosynthetic_gene_cluster (100% of 


























































SW-163_biosynthetic_gene_cluster (10% of 











































Hygrocin_biosynthetic_gene_cluster (6% of 












WS9326_biosynthetic_gene_cluster (10% of 










A-503083_biosynthetic_gene_cluster (7% of 













Rapamycin_biosynthetic_gene_cluster (14% of 





















Kanamycin_biosynthetic_gene_cluster (53% of 






























Feglymycin_biosynthetic_gene_cluster (36% of 




























Salinomycin_biosynthetic_gene_cluster (6% of 
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Streptomyces sp. SAT1 
Cluster 1 Lantipeptid
e 
1 24200 Herboxidiene_biosynthetic_gene_cluster (7% of 







Scabichelin_biosynthetic_gene_cluster (30% of 










Isorenieratene_biosynthetic_gene_cluster (85% of 



















Herboxidiene_biosynthetic_gene_cluster (2% of 
genes show similarity) 
BGC00010
65_c1 




Stenothricin_biosynthetic_gene_cluster (13% of 
genes show similarity) 
BGC00004
31_c1 




Oxazolomycin_biosynthetic_gene_cluster (9% of 








Herboxidiene_biosynthetic_gene_cluster (7% of 








Ectoine_biosynthetic_gene_cluster (100% of 









Melanin_biosynthetic_gene_cluster (60% of 



















































Nataxazole_biosynthetic_gene_cluster (77% of 























Grincamycin_biosynthetic_gene_cluster (5% of 





















Bafilomycin_biosynthetic_gene_cluster (94% of 










Griseobactin_biosynthetic_gene_cluster (47% of 























Teichomycin_biosynthetic_gene_cluster (66% of 





























Coelichelin_biosynthetic_gene_cluster (100% of 





















Herboxidiene_biosynthetic_gene_cluster (8% of 










Naringenin_biosynthetic_gene_cluster (100% of 











Nucleocidin_biosynthetic_gene_cluster (47% of 
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Holomycin_biosynthetic_gene_cluster (100% of 










































































Kanamycin_biosynthetic_gene_cluster (1% of 



















Tunicamycin_biosynthetic_gene_cluster (92% of 























Melanin_biosynthetic_gene_cluster (100% of 










Clavams_biosynthetic_gene_cluster (81% of 





















Lactonamycin_biosynthetic_gene_cluster (3% of 




























Ectoine_biosynthetic_gene_cluster (100% of 













Daptomycin_biosynthetic_gene_cluster (12% of 

















Bafilomycin_biosynthetic_gene_cluster (66% of 












Skyllamycin_biosynthetic_gene_cluster (6% of 










GE37468_biosynthetic_gene_cluster (100% of 





























Tiancimycin_biosynthetic_gene_cluster (16% of 























Apoptolidin_biosynthetic_gene_cluster (30% of 
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Meilingmycin_biosynthetic_gene_cluster (3% of 







































FR900098_biosynthetic_gene_cluster (27% of 










Marineosin_biosynthetic_gene_cluster (9% of 
































Avilamycin_A_biosynthetic_gene_cluster (5% of 










A-503083_biosynthetic_gene_cluster (7% of 



























Meilingmycin_biosynthetic_gene_cluster (16% of 













Blasticidin_biosynthetic_gene_cluster (17% of 












Blasticidin_biosynthetic_gene_cluster (60% of 










Lactazole_biosynthetic_gene_cluster (66% of 
























Napsamycin_biosynthetic_gene_cluster (82% of 





















Streptothricin_biosynthetic_gene_cluster (8% of 



















Kanamycin_biosynthetic_gene_cluster (1% of 






















Melanin_biosynthetic_gene_cluster (57% of 

































Toyocamycin_biosynthetic_gene_cluster (30% of 





































Herboxidiene_biosynthetic_gene_cluster (8% of 

















Cinnamycin_biosynthetic_gene_cluster (14% of 

















Ectoine_biosynthetic_gene_cluster (100% of 












Chaxapeptin_biosynthetic_gene_cluster (28% of 










Kanamycin_biosynthetic_gene_cluster (2% of 












Melanin_biosynthetic_gene_cluster (80% of 











































Streptomyces sp. S10(2016) 




A-500359s_biosynthetic_gene_cluster (5% of 








- -   




Melanin_biosynthetic_gene_cluster (57% of 








Feglymycin_biosynthetic_gene_cluster (57% of 








Ectoine_biosynthetic_gene_cluster (100% of 










SCO-2138_biosynthetic_gene_cluster (71% of 








Istamycin_biosynthetic_gene_cluster (5% of 

















Platencin_biosynthetic_gene_cluster (9% of 












Pristinamycin_biosynthetic_gene_cluster (3% of 



































































































Lividomycin_biosynthetic_gene_cluster (6% of 










Telomycin_biosynthetic_gene_cluster (61% of 

























Coelichelin_biosynthetic_gene_cluster (100% of 
























Oxazolomycin_biosynthetic_gene_cluster (9% of 












7-prenylisatin_biosynthetic_gene_cluster (60% of 




















Herbimycin_biosynthetic_gene_cluster (10% of 








Lincomycin_biosynthetic_gene_cluster (75% of 








Skyllamycin_biosynthetic_gene_cluster (12% of 










Melanin_biosynthetic_gene_cluster (57% of 








Pristinamycin_biosynthetic_gene_cluster (12% of 








Coelibactin_biosynthetic_gene_cluster (63% of 








Herboxidiene_biosynthetic_gene_cluster (8% of 








- - 2 CYP183Y1; 
CYP157C22 




Pristinamycin_biosynthetic_gene_cluster (2% of 










Ectoine_biosynthetic_gene_cluster (100% of 



















Istamycin_biosynthetic_gene_cluster (5% of 





















Colabomycin_biosynthetic_gene_cluster (13% of 














Pyralomicin_biosynthetic_gene_cluster (18% of 









































Teichomycin_biosynthetic_gene_cluster (88% of 












Pamamycin_biosynthetic_gene_cluster (95% of 
























Medermycin_biosynthetic_gene_cluster (13% of 












Grincamycin_biosynthetic_gene_cluster (8% of 










Kanamycin_biosynthetic_gene_cluster (4% of 










Coelichelin_biosynthetic_gene_cluster (100% of 























Meilingmycin_biosynthetic_gene_cluster (5% of 
































Scabichelin_biosynthetic_gene_cluster (20% of 









Daptomycin_biosynthetic_gene_cluster (4% of 









Incednine_biosynthetic_gene_cluster (5% of 









Antimycin_biosynthetic_gene_cluster (93% of 









Lomofungin_biosynthetic_gene_cluster (8% of 



















(75% of genes show similarity)
BGC00006
57_c1 




Ebelactone_biosynthetic_gene_cluster (60% of 

















- - 1 CYP157C31 




Nystatin_biosynthetic_gene_cluster (100% of 
















Merochlorin_biosynthetic_gene_cluster (4% of 
































Actinomycin_biosynthetic_gene_cluster (10% of 






















Echosides_biosynthetic_gene_cluster (11% of 









Erythromycin_biosynthetic_gene_cluster (60% of 






























Desotamide_biosynthetic_gene_cluster (63% of 
















Albonoursin_biosynthetic_gene_cluster (83% of 









Meridamycin_biosynthetic_gene_cluster (5% of 









Legonaridin_biosynthetic_gene_cluster (55% of 











TP-1161_biosynthetic_gene_cluster (37% of 













Salinomycin_biosynthetic_gene_cluster (6% of 






























Ectoine_biosynthetic_gene_cluster (100% of 























Streptomycin_biosynthetic_gene_cluster (12% of 











































Friulimicin_biosynthetic_gene_cluster (12% of 
























Leinamycin_biosynthetic_gene_cluster (2% of 












Zorbamycin_biosynthetic_gene_cluster (6% of 













Nystatin_biosynthetic_gene_cluster (72% of 























Mycobacterium africanum GM041182 
Cluste
r 



































Glycopeptidolipid_biosynthetic_gene_cluster (13% of 





















Glycopeptidolipid_biosynthetic_gene_cluster (20% of 























- -   











































































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 


































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 





















Glycopeptidolipid_biosynthetic_gene_cluster (20% of 























Glycopeptidolipid_biosynthetic_gene_cluster (20% of 





















Glycopeptidolipid_biosynthetic_gene_cluster (20% of 


































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 























Glycopeptidolipid_biosynthetic_gene_cluster (10% of 


































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 





















Glycopeptidolipid_biosynthetic_gene_cluster (20% of 




































































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 























Glycopeptidolipid_biosynthetic_gene_cluster (10% of 

























Glycopeptidolipid_biosynthetic_gene_cluster (20% of 












Glycopeptidolipid_biosynthetic_gene_cluster (10% of 





















Glycopeptidolipid_biosynthetic_gene_cluster (20% of 


































Glycopeptidolipid_biosynthetic_gene_cluster (20% of 
































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 























Glycopeptidolipid_biosynthetic_gene_cluster (10% of 
































Glycopeptidolipid_biosynthetic_gene_cluster (13% of 





















Glycopeptidolipid_biosynthetic_gene_cluster (20% of 







































































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 





















Glycopeptidolipid_biosynthetic_gene_cluster (10% of 
genes show similarity) 
BGC000036
5_c1 












Glycopeptidolipid_biosynthetic_gene_cluster (25% of 




















Glycopeptidolipid_biosynthetic_gene_cluster (10% of 



















Glycopeptidolipid_biosynthetic_gene_cluster (38% of 



















































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 





















Glycopeptidolipid_biosynthetic_gene_cluster (10% of 
genes show similarity) 
BGC000036
5_c1 































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 


























Glycopeptidolipid_biosynthetic_gene_cluster (20% of 
























Glycopeptidolipid_biosynthetic_gene_cluster (20% of 























Glycopeptidolipid_biosynthetic_gene_cluster (17% of 
genes show similarity) 
BGC000036
2_c1 






















Glycopeptidolipid_biosynthetic_gene_cluster (10% of 























Glycopeptidolipid_biosynthetic_gene_cluster (10% of 


































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 




























Glycopeptidolipid_biosynthetic_gene_cluster (20% of 

























Glycopeptidolipid_biosynthetic_gene_cluster (20% of 























Glycopeptidolipid_biosynthetic_gene_cluster (17% of 























Glycopeptidolipid_biosynthetic_gene_cluster (10% of 























Glycopeptidolipid_biosynthetic_gene_cluster (10% of 




    Mycobacterium tuberculosis KZN 
4207 






























Glycopeptidolipid_biosynthetic_gene_cluster (10% of 




























Glycopeptidolipid_biosynthetic_gene_cluster (20% of 

























Glycopeptidolipid_biosynthetic_gene_cluster (20% of 


























Glycopeptidolipid_biosynthetic_gene_cluster (17% of 























Glycopeptidolipid_biosynthetic_gene_cluster (10% of 























Glycopeptidolipid_biosynthetic_gene_cluster (10% of 




    Mycobacterium  tuberculosis RGTB3
27 


















Glycopeptidolipid_biosynthetic_gene_cluster (20% of 













































Glycopeptidolipid_biosynthetic_gene_cluster (20% of 












































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 




    Mycobacterium 
tuberculosis CDC1551 












Glycopeptidolipid_biosynthetic_gene_cluster (25% of 





















Glycopeptidolipid_biosynthetic_gene_cluster (10% of 












































































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 























Glycopeptidolipid_biosynthetic_gene_cluster (10% of 
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    Mycobacterium tuberculosis strains 
CCDC5079 


































Glycopeptidolipid_biosynthetic_gene_cluster (13% of 





















Glycopeptidolipid_biosynthetic_gene_cluster (20% of 





























































































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 
















Glycopeptidolipid_biosynthetic_gene_cluster (25% of 





















Glycopeptidolipid_biosynthetic_gene_cluster (10% of 





















Glycopeptidolipid_biosynthetic_gene_cluster (20% of 






















































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 























Glycopeptidolipid_biosynthetic_gene_cluster (10% of 




    Mycobacterium 
tuberculosis Beijing/NITR203 
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Cluste






















Glycopeptidolipid_biosynthetic_gene_cluster (20% of 











Glycopeptidolipid_biosynthetic_gene_cluster (10% of 



















Glycopeptidolipid_biosynthetic_gene_cluster (20% of 






















Glycopeptidolipid_biosynthetic_gene_cluster (20% of 




















Glycopeptidolipid_biosynthetic_gene_cluster (20% of 

































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 





















Glycopeptidolipid_biosynthetic_gene_cluster (13% of 











Glycopeptidolipid_biosynthetic_gene_cluster (10% of 











Glycopeptidolipid_biosynthetic_gene_cluster (20% of 











Glycopeptidolipid_biosynthetic_gene_cluster (10% of 








































Glycopeptidolipid_biosynthetic_gene_cluster (20% of 



















































Glycopeptidolipid_biosynthetic_gene_cluster (13% of 
genes show similarity) 
BGC000036
5_c1 

































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 





















































































Glycopeptidolipid_biosynthetic_gene_cluster (13% of 




    Mycobacterium 
tuberculosis EAI5/NITR206 

























Glycopeptidolipid_biosynthetic_gene_cluster (20% of 










Glycopeptidolipid_biosynthetic_gene_cluster (13% of 





















Glycopeptidolipid_biosynthetic_gene_cluster (20% of 






































































    Mycobacterium 
tuberculosis Erdman=ATCC 35801 












Glycopeptidolipid_biosynthetic_gene_cluster (15% of 












Glycopeptidolipid_biosynthetic_gene_cluster (20% of 












Glycopeptidolipid_biosynthetic_gene_cluster (13% of 





















Glycopeptidolipid_biosynthetic_gene_cluster (20% of 













































- -   











Glycopeptidolipid_biosynthetic_gene_cluster (10% of 























Glycopeptidolipid_biosynthetic_gene_cluster (10% of 


































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 





















Glycopeptidolipid_biosynthetic_gene_cluster (20% of 




















































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 























Glycopeptidolipid_biosynthetic_gene_cluster (10% of 




    Mycobacterium canetti CIPT 
140010059 
































Glycopeptidolipid_biosynthetic_gene_cluster (13% of 





















Glycopeptidolipid_biosynthetic_gene_cluster (23% of 


































Glycopeptidolipid_biosynthetic_gene_cluster (20% of 


































Glycopeptidolipid_biosynthetic_gene_cluster (13% of 























Glycopeptidolipid_biosynthetic_gene_cluster (10% of 
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    Mycobacterium canetti CIPT 
140060008 






























Glycopeptidolipid_biosynthetic_gene_cluster (10% of 





















Glycopeptidolipid_biosynthetic_gene_cluster (20% of 


































Glycopeptidolipid_biosynthetic_gene_cluster (20% of 
































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 























Glycopeptidolipid_biosynthetic_gene_cluster (10% of 




    Mycobacterium canetti CIPT 
140710010 
































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 





















Glycopeptidolipid_biosynthetic_gene_cluster (20% of 











































































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 























Glycopeptidolipid_biosynthetic_gene_cluster (13% of 




    Mycobacterium bovis AF 2122/97    


































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 



















Glycopeptidolipid_biosynthetic_gene_cluster (20% of 



























































































Glycopeptidolipid_biosynthetic_gene_cluster (13% of 
genes show similarity) 
BGC000036
5_c1 




































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 



















Glycopeptidolipid_biosynthetic_gene_cluster (20% of 






























































































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 




    Mycobacterium bovis BCG Korea 
1168P 


































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 





















Glycopeptidolipid_biosynthetic_gene_cluster (20% of 








































































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 























Glycopeptidolipid_biosynthetic_gene_cluster (10% of 






































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 





















Glycopeptidolipid_biosynthetic_gene_cluster (20% of 



































































































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 




    Mycobacterium bovis BCG Toyko 
172 


































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 





















Glycopeptidolipid_biosynthetic_gene_cluster (20% of 
































































































Glycopeptidolipid_biosynthetic_gene_cluster (10% of 




    Mycobacterium abscessus ATCC 
19977 











































Glycopeptidolipid_biosynthetic_gene_cluster (20% of 






































































Glycopeptidolipid_biosynthetic_gene_cluster (16% of 










































Glycopeptidolipid_biosynthetic_gene_cluster (94% of 



















Glycopeptidolipid_biosynthetic_gene_cluster (52% of 




    Mycobacterium abscessus subsp. 
bolletti 50594 















































Glycopeptidolipid_biosynthetic_gene_cluster (20% of 




























































Glycopeptidolipid_biosynthetic_gene_cluster (13% of 









































Glycopeptidolipid_biosynthetic_gene_cluster (52% of 



















































Glycopeptidolipid_biosynthetic_gene_cluster (20% of 

























































- -   









Glycopeptidolipid_biosynthetic_gene_cluster (13% of 
































Glycopeptidolipid_biosynthetic_gene_cluster (94% of 



















Glycopeptidolipid_biosynthetic_gene_cluster (47% of 















































Glycopeptidolipid_biosynthetic_gene_cluster (20% of 






































































Glycopeptidolipid_biosynthetic_gene_cluster (16% of 







































Glycopeptidolipid_biosynthetic_gene_cluster (94% of 



















Glycopeptidolipid_biosynthetic_gene_cluster (52% of 




    Mycobacterium abscessus subsp. 
bolletti MA 1948 











































Glycopeptidolipid_biosynthetic_gene_cluster (20% of 






































































Glycopeptidolipid_biosynthetic_gene_cluster (16% of 




































Glycopeptidolipid_biosynthetic_gene_cluster (94% of 


















Glycopeptidolipid_biosynthetic_gene_cluster (52% of 











Glycopeptidolipid_biosynthetic_gene_cluster (52% of 



















Glycopeptidolipid_biosynthetic_gene_cluster (94% of 


























Glycopeptidolipid_biosynthetic_gene_cluster (13% of 



























































Glycopeptidolipid_biosynthetic_gene_cluster (20% of 


































































Glycopeptidolipid_biosynthetic_gene_cluster (26% of 






























































Glycopeptidolipid_biosynthetic_gene_cluster (69% of 







































- -   
    Mycobacterium avium subsp. 
paratuberculosis K10 






























Glycopeptidolipid_biosynthetic_gene_cluster (35% of 























































Glycopeptidolipid_biosynthetic_gene_cluster (13% of 
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Figure 4. 3 Comparative analysis of types of BGCs between Streptomyces species (A) and 
mycobacterial species (B). The numbers next to bars represent the number of secondary metabolite 
BGCs and their percentage in the total number of BGCs found in 48 Streptomyces species (A) or 
60 mycobacterial species (B). Comparative analysis of types of secondary metabolite BGCs in 
Streptomyces species and mycobacterial species was presented in Table 4.1. Furthermore, 
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comprehensive comparative analysis of different types of secondary metabolite BGCs between 
Streptomyces and Mycobacterium is presented in Table 4.2. 
As mentioned earlier, quite a big difference was observed with respect to the types of secondary 
metabolite BGCs between Streptomyces and mycobacterial species (Figure 4.3 and Table 4.2). 
Among 159 types of secondary metabolite BGCs found in Streptomyces species, only 13 types of 
BGCs contributed 80% to the total percentage of BGCs (Figure 4.3A), suggesting that the 
secondary metabolites produced by these BGCs were highly important in Streptomyces species’ 
physiology. The secondary metabolite BGC terpene was dominant, followed by siderophore, Nrps 
and T1pks in Streptomyces species (Figure 4.3A and Table 4.2). Among 18 types of secondary 
metabolite BGCs identified in mycobacterial species, Nrps was the dominant secondary metabolite 
BGC, followed by Other, T1pks and T1pks-Nrps (Figure 4.3B and Table 4.2). Despite the presence 
of 15 common types of secondary metabolite BGCs between the genera Streptomyces and 
Mycobacterium, large differences were observed in terms of the number of BGCs (Figure 4.4), 
indicating that the selective enrichment of particular secondary metabolite BGCs in both genera is 
possibly due to the different lifestyle, as discussed in the subsequent section. 
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Table 4. 2 Comparative analysis of secondary metabolite BGCs between the genera Streptomyces 
and Mycobacterium.  
 
Secondary metabolite BGC Number of clusters 
 Streptomyces Mycobacterium 
Nrps 117 177 
Other 94 159 
T1pks 94 149 
T1pks-Nrps 53 146 
Bacteriocin 76 71 
Terpene 229 60 
T3pks 41 58 
T3pks-T1pks 0 38 
Ectoine 50 15 
Ectoine-T1pks-Nrps 0 5 
T2pks 41 4 
T2pks-nrps 2 4 
Arylpolyene 3 4 
Lantipeptide 87 3 
Amglyccycl 7 2 
T1pks-Ectoine-Nrps 0 1 
otherKs 8 1 
linaridin 3 1 
Siderophore 121 Not identified 
Butyrolactone 58 Not identified 
Melanin 40 Not identified 
Lassopeptide 35 Not identified 
Thiopeptide 21 Not identified 
T1pks-Otherks 13 Not identified 
Indole 9 Not identified 
Bacteriocin-Lantipeptide 8 Not identified 
Transatpks-T1pks-Nrps 8 Not identified 
Bacteriocin-Nrps 8 Not identified 
T3pks-Nrps 7 Not identified 
Terpene-Nrps 7 Not identified 
Lantipeptide-Nrps 5 Not identified 
Melanin-Nrps 5 Not identified 
T2pks-Terpene 5 Not identified 
Ladderane 5 Not identified 
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Terpene-T1pks 5 Not identified 
Transatpks-Nrps 5 Not identified 
Nrps-T1pks-Otherks 4 Not identified 
Lantipeptide-T1pks-Nrps 4 Not identified 
T1pks-Butyrolactone-Nrps 4 Not identified 
T2pks-Otherks 4 Not identified 
Lantipeptide-Terpene 4 Not identified 
T2pks-Butryolactone 4 Not identified 
Melanin-Terpene 4 Not identified 
T3pks-Terpene-Nrps 3 Not identified 
T2pks-T1pks-Otherks 3 Not identified 
Ladderane-Arylpolyene-Nrps 3 Not identified 
Arylpolyene-Ladderane 3 Not identified 
Bacteriocin-T1pks-Nrps 3 Not identified 
T1pks-Siderophore 3 Not identified 
Blactam 3 Not identified 
Otherks-Nrps 3 Not identified 
Lantipeptide-Terpene-Nrps 3 Not identified 
T3pks-T1pks-Nrps 3 Not identified 
Nucleoside 3 Not identified 
T1pks-Butyrolactone-otherks 2 Not identified 
Butyrolactone-Otherks 2 Not identified 
T1pks-Linaridin 2 Not identified 
Hserlactone 2 Not identified 
T1pks-Lassopeptide 2 Not identified 
T3pks-Terpene 2 Not identified 
Nrps-Otherks 2 Not identified 
Blactam-T1pks-Nrps 2 Not identified 
Phenazine-Nrps 2 Not identified 
T2pks-Ladderane-Nrps 2 Not identified 
T2pks-T1pks 2 Not identified 
Bacteriocin-Terpene 2 Not identified 
Lassopeptide-Nrps 2 Not identified 
Lantipeptide-Lassopeptide 2 Not identified 
T2pks-Oligosaccharide-Nucleoside-Nrps 2 Not identified 
Butyrolactone-T1pks-Nrps 2 Not identified 
Terpene-T3pks-T1pks-Nrps 2 Not identified 
T2pks-Oligosaccharide-Nrps-Otherks 2 Not identified 
Terpene-T1pks-Nrps 2 Not identified 
Bacteriocin-T1pks 2 Not identified 
Phosphoglycolipid 2 Not identified 
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Thiopeptide-Bacteriocin 2 Not identified 
T1pks-Butyrolactone 1 Not identified 
T1pks-Terpene 1 Not identified 
Transatpks-T1pks-Otherks-Nrps 1 Not identified 
Bacteriocin-Bottromycin 1 Not identified 
Butyrolactone-T1pks-Otherks 1 Not identified 
Indole-T1pks 1 Not identified 
T2pks-Butyrolactone-Nrps 1 Not identified 
Bacteriocin-Lantipeptide-T1pks-Otherks-Nrps 1 Not identified 
Ectoine-Terpene 1 Not identified 
Transatpks-Otherks-Nrps 1 Not identified 
Bacteriocin-Lantipeptide-T1pks 1 Not identified 
Nrps-Furan-T1pks-Otherks 1 Not identified 
Siderophore-Nrps 1 Not identified 
T2pks-Oligosaccharide-Otherks 1 Not identified 
Transatpks-Terpene-Nrps 1 Not identified 
Ladderane-Nrps 1 Not identified 
Butyrolactone-Terpene 1 Not identified 
Bacteriocin-Oligosaccharide 1 Not identified 
Terpene-T3pks-Cyanobactin-Nrps 1 Not identified 
Phosphonate 1 Not identified 
Arylpolyene-Nrps 1 Not identified 
Melanin-Arylpolyene-Ladderane 1 Not identified 
T1pks-Phenazine 1 Not identified 
Terpene-Ectoine 1 Not identified 
Bacteriocin-Otherks 1 Not identified 
Nrps-Transatpks-T1pks-Otherks 1 Not identified 
Thiopeptide-T2pks-Otherks-Nrps 1 Not identified 
Nrps-Ladderane 1 Not identified 
Lantipeptide-Lassopeptide-Nrps 1 Not identified 
T1pks-Arylpolyene-Ladderane 1 Not identified 
Bacteriocin-Nrps-Lantipeptide-T1pks-Otherks 1 Not identified 
Nrps-Arylpolyene-Ladderane 1 Not identified 
T3pks-Otherks-Butyrolactone-Nrps 1 Not identified 
Otherks-Butyrolactone-Nrps 1 Not identified 
Butyrolactone-T1pks 1 Not identified 
T2pks-Lantipeptide-Terpene 1 Not identified 
T1pks-Arylpolyene 1 Not identified 
Bacteriocin-Butyrolactone 1 Not identified 
Thiopeptide-T1pks 1 Not identified 
T3pks-Fused-Nrps 1 Not identified 
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Transatpks 1 Not identified 
Cyanobactin-T1pks-Nrps 1 Not identified 
T2pks-Oligosaccharide 1 Not identified 
Lantipeptide-T1pks 1 Not identified 
Lantipeptide-Linaridin 1 Not identified 
Linaridin-T1pks-Lassopeptide-Nrps 1 Not identified 
Terpene-Otherks 1 Not identified 
T2pks-T3pks 1 Not identified 
T1pks-Transatpks-Terpene 1 Not identified 
Fused 1 Not identified 
T3pks-Terpene-Otherks 1 Not identified 
Phenazine 1 Not identified 
T1pks-Terpene-Nrps 1 Not identified 
Oligosaccharide-T1pks-Nrps 1 Not identified 
Oligosaccharide-Ectoine-T2pks-Nrps-T1pks-Otherks 1 Not identified 
Thiopeptide-Nrps 1 Not identified 
Thiopeptide-T2pks 1 Not identified 
Ectoine-Nrps 1 Not identified 
T2pks-Ectoine-Otherks 1 Not identified 
Thiopeptide-T1pks-Nrps 1 Not identified 
Ectoine-Butyrolactone 1 Not identified 
Transatpks-T1pks-Otherks-Nrps 1 Not identified 
Bacteriocin-Lassopeptide-Nrps 1 Not identified 
T2pks-T3pks-Otherks 1 Not identified 
Ectoine-T1pks-Otherks 1 Not identified 
Butyrolactone-Amglyccycl-T1pks-Nrps 1 Not identified 
Nrps-T2pks-Otherks-T1pks-Phenazine 1 Not identified 
Nrps-Transatpks-Terpene-Otherks 1 Not identified 
Butyrolactone-Amglyccycl 1 Not identified 
T3pks-Butyrolactone 1 Not identified 
Nucleoside-Lassopeptide-Nrps 1 Not identified 
Phosphonate-Nrps 1 Not identified 
Thiopeptide-Terpene 1 Not identified 
Bacteriocin-Terpene-Nrps 1 Not identified 
Indole-Terpene-Nrps 1 Not identified 
Blactam-Nrps 1 Not identified 
Phosphonate-Bacteriocin 1 Not identified 
Siderophore-T1pks-Nrps 1 Not identified 
Phosphonate-Terpene 1 Not identified 
Lantipeptide-T1pks-Otherks 1 Not identified 
Phosphonate-T3pks-Nrps-Ladderane 1 Not identified 
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Indole-T3pks 1 Not identified 
Amglyccycl-Butyrolactone 1 Not identified 
Bacteriocin-T2pks 1 Not identified 
Terpene-Butyrolactone 1 Not identified 
Nrps-Siderophore 1 Not identified 




Figure 4. 4 Comparative analysis of secondary metabolite BGCs commonly found in both 
Streptomyces and mycobacterial species. The number on top of each bar represents the number of 
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4.2. Streptomyces species have a large and diverse number of P450s in secondary metabolite 
BGCs 
Comparative analysis of P450s that are part of secondary metabolite BGCs revealed the presence 
of a large number of diverse P450s as part of these secondary metabolite BGCs in Streptomyces, 
compared to Mycobacterium (Figures 4.1 and 4.5; Tables 4.3 and 4.4). Not all secondary 
metabolite BGCs found in Streptomyces and Mycobacterium have P450s. Among 1 461 in 
Streptomyces species, only 554 secondary metabolite BGCs were found to have P450s, whereas 
in mycobacterial species, among 898 only 204 secondary metabolite BGCs have P450s (Figure 
4.1). Moreover, not all types of secondary metabolite BGCs have P450s: 64% and 50% of types 
of secondary metabolite BGCs of respectively Streptomyces and Mycobacterium were found to 
have P450s (Figures 4.1 and 4.5; Tables 4.3 and 4.4). Furthermore, a large difference was observed 
in the number of different P450 families that are part of secondary metabolite BGCs between the 
genera Streptomyces and Mycobacterium; the former genus has 88 P450 families and the latter 
only 31 P450 families, strongly indicating the possibility that diverse P450s are involved in the 
generation of diverse secondary metabolites in Streptomyces compared to Mycobacterium. 
Overall, 554 and 204 P450s were found to be part of secondary metabolite BGCs in Streptomyces 
and mycobacterial species (Figures 4.1 and 4.5; Tables 4.3 and 4.4). 
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Figure 4. 5 Comparative analysis of P450s associated with secondary metabolism. Comparative 
analysis of BGCs containing P450s in 48 Streptomyces species (A) and 60 mycobacterial species 
(B).  Numbers next to BGCs indicate the number of BGCs and their percentage in the total number 
of BGCs containing P450s (for details see Tables 4.3 and 4.4). Comparative analysis of P450 
families that are part of secondary metabolite BGCs in Streptomyces species (C) and mycobacterial 
species (D). The P450 families that are dominantly present in different BGCs are presented in the 
figure. The number after the P450 name indicates the number of member P450s. Detailed 
information on P450s that are part of BGCs is presented in Table 4.5. 
Table 4. 3 Comparative analysis of secondary metabolite biosynthetic gene clusters and P450s that 




Cluster name Number 
of P450s 
P450 name 
sco T3pks 1 CYP158A2 
 Terpene 1 CYP170A1  
 T3pks-Terpene-Nrps 1 CYP105N1 
sma T1pks 2 CYP105D6; CYP105P1 
 Nrps 1 CYP147B1 
 Nrps-T1pks-Otherks 2 CYP178A1; CYP178A3P 
 T1pks 1 CYP171A1 
 Terpene 1 CYP180A1 
 T2pks-T1pks-Otherks 2 CYP107Y1; CYP181A1 
 T1pks 2 CYP107W1; CYP105B23 
 Terpene 1 CYP183A1 
 Terpene 1 CYP170A2 
 Butyrolactone-Otherks 2 CYP107V1; CYP107U2 
 T3pks 1 CYP158A3 
 T1pks 1 CYP105R1 
sgr T1pks-Nrps 1 CYP105D1  
 Melanin 1 CYP124G2  
 T1pks-Nrps 3 CYP162C1; CYP208A1; CYP154M2 
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T1pks-Nrps 1 CYP107BX5 
Nrps 1 CYP107BY1 
Ladderane-Arylpolyene-Nrps 2 CYP163B5; CYP107BZ1 




sgb T3pks 1 CYP107F4 
Arylpolyene-Ladderane 1 CYP1373A2 
Bacteriocin-T1pks-Nrps 1 CYP107BX10 
Melanin 1 CYP124G14 
T1pks-Nrps 1 CYP105D30 
scb Terpene 1 CYP154A4 
Lantipeptide-Nrps 4 CYP246A1; CYP1048A1; CYP156D1; 
CYP154L1 
T1pks-Nrps 1 CYP107AM1 
Bacteriocin-Bottromycin 1 CYP283A1 
Butyrolactone-T1pks-Otherks 1 CYP107AL1 
Terpene 1 CYP157C5 
Indole-T1pks 1 CYP156B2 
T1pks 1 CYP107AK1 
ssx Melanin 1 CYP124G3 
Nrps 1 CYP105N1 
T2pks-T1pks-Otherks 2 CYP181A1; CYP107Y1 
T1pks 2 CYP105AZ1; CYP105AZ2 
T1pks-Nrps 1 CYP107BX4 
T2pks-Butyrolactone-Nrps 1 CYP105A4 
svl Terpene 2 CYP107BW1; CYP1013A2 
Nrps 2 CYP162A3; CYP107CK1 
T1pks 1 CYP124B3 
T1pks 2 CYP107BW1; CYP105AX1 
Otherks 2 CYP183F2; CYP105AV1 
Bacteriocin-Lantipeptide-
T1pks-Otherks-Nrps 
4 CYP105AQ2; CYP155A5; CYP107E9; 
CYP105AN3 
T1pks 1 CYP107AD1 
Lantipeptide-T1pks-Nrps 1 CYP105AY1 
T1pks 1 CYP105U1 
Terpene 2 CYP156C9; CYP125A20 
Indole 2 CYP107U9; CYP156B6 
Ladderane-Arylpolyene-Nrps 3 CYP163B4; CYP107CF1; 
CYP107CE1 
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 Terpene 1 CYP147F5 
sct T1pks 2 CYP107AS; CYP107CR1 
 Lantipeptide 1 CYP107AE6 
 T1pks-Nrps 1 CYP184A4 
 Transatpks-T1pks-Nrps 2 CYP107CS1; CYP107W2 
 T3pks-Terpene 1 CYP158A13 
 Lantipeptide 1 CYP105AA10 
 T1pks-Butyrolactone-Nrps 2 CYP107CT1; CYP105B25 
scy T1pks 3 CYP107AS; CYP1274A1; 
CYP107CR1 
 Lantipeptide 1 CYP107AE6 
 T1pks-Nrps 1 CYP184A4 
 Transatpks-T1pks-Nrps 2 CYP107CS1; CYP107W2 
 T3pks-Terpene 1 CYP158A13 
 Lantipeptide 1 CYP105AA10 
 T1pks-Butyrolactone-Nrps 2 CYP107CT1; CYP105B25 
sfa Blactam-T1pks-Nrps 2 CYP247A3; CYP107BX5 
 T1pks 2 CYP105AZ2; CYP105AZ1 
 T1pks-Nrps 3 CYP1029A2; CYP1423A2; 
CYP285A2 
 Terpene 1 CYP157K1 
 Melanin 1 CYP124G4 
 Nrps 2 CYP1035A4; CYP156B9 
sbh Bacteriocin-T1pks-Nrps 2 CYP183C1; CYP183D1 




 Transatpks-T1pks-Nrps 3 CYP105H6; CYP107BK1; CYP171A2 
 Nrps 2 CYP107BM3; CYP157B13 
 T1pks-Nrps 1 CYP113G1 
 Other 1 CYP154P1 
 T1pks-Nrps 1 CYP1037A1 
 Otherks 1 CYP268A4 
 T1pks 1 CYP124B2 
 Otherks-Nrps 1 CYP163C1 
 Transatpks-Terpene-Nrps 2 CYP161C1; CYP183A2 
shy T1pks 1 CYP105B22  
 Terpene 1 CYP107X1  
 Nrps 1 CYP163B6 
 Nrps 1 CYP285B1 
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 T1pks 2 CYP105AZ2; CYP105AZ1  
 T3pks 1 CYP158A14  
 Terpene 1 CYP170A10  
 Terpene 1 CYP180A6  
 Bacteriocin-Nrps 1 CYP113K3  
sho T1pks 1 CYP105B22  
 Terpene 1 CYP107X1 
 Nrps 1 CYP163B6 
 Nrps 1 CYP285B1 
 T1pks 2 CYP105AZ2; CYP105AZ1  
 T3pks 1 CYP158A14  
 Terpene 1 CYP170A10  
 Terpene 1 CYP180A6  
 Bacteriocin-Nrps 1 CYP113K3  
sve Lantipeptide-Terpene 1 CYP157C14 
 Indole 1 CYP245A3 
 Other 1 CYP121A2 
 T3pks 1 CYP158A5 
 Other 2 CYP105AC2; CYP180A5 
 Ladderane-Nrps 4 CYP1056A1; CYP107CL1; 
CYP162A4; CYP163B5 
sdv T1pks-Nrps 1 CYP105BA1 
 Other 1 CYP1005B2 
 Bacteriocin-Lantipeptide 1 CYP179B1 
 Terpene 1 CYP183K1 
 Lantipeptide-T1pks-Nrps 1 CYP179A3 
 Butyrolactone-Terpene 1 CYP180A6 
 Bacteriocin-Oligosaccharide 2 CYP107CN1; CYP107CP1 
 Terpene-Nrps 1 CYP170A9 
 T1pks-Nrps 3 CYP113J1; CYP113J2; CYP162A5 
 Otherks-Nrps 2 CYP125A22; CYP163C2 
 T3pks 1 CYP158A7 
 Terpene-T3pks-Cyanobactin-
Nrps 
2 CYP1041A2; CYP1058A1 
salb T1pks-Nrps 1 CYP107BX2 
 Otherks 1 CYP1420A1  
 Nrps 1 CYP146A3 
 Terpene 1 CYP170B5  
 Lantipeptide 1 CYP154A1  
 T3pks 1 CYP107F4  
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Lantipeptide-T1pks-Nrps 1 CYP105H3 
sals Nrps 1 CYP105BK3 
T1pks-Butyrolactone-Nrps 1 CYP107EJ1 
T1pks-Otherks 2 CYP113Y1; CYP105DB1 
T1pks 1 CYP107DU1 
Terpene 1 CYP170B5 
Arylpolyene-Nrps 1 CYP107T3 
Arylpolyene 1 CYP107KW1 
T2pks-Otherks 1 CYP1193A1 
T1pks-Nrps 1 CYP1194A1 
strp Nrps 2 CYP156B9; CYP1035A4 
Melanin 1 CYP124G4 
Terpene 1 CYP157K1 
T1pks-Nrps 3 CYP285A2, CYP1423A2, CYP1029A2 
T1pks 2 CYP105AZ1; CYP105AZ2 
Bacteriocin-Otherks 1 CYP1057A1 
Blactam-T1pks-Nrps 2 CYP107BX5; CYP247A3 
sfi T3pks 1 CYP107F4 
T1pks-Nrps 1 CYP107BX3 
Melanin 1 CYP124G2 
sci Transatpks-T1pks-Nrps 2 CYP107CQ1; CYP105AJ2 
Bacteriocin 2 CYP1059A1; CYP105B21 
T3pks 1 CYP158A2 
Terpene 1 CYP170A10 
T1pks 2 CYP105BC1; CYP105AH2 
Terpene 1 CYP180A6 
Terpene 1 CYP183A4 
Bacteriocin-Nrps 1 CYP113K3 
Transatpks-T1pks-Nrps 2 CYP105AJ2; CYP107CQ1 
src T1pks 1 CYP105AX1 
T1pks 1 CYP124B3 
T1pks-Nrps 3 CYP161D1; CYP105AT1; 
CYP107L12 
Terpene 1 CYP1013A2 
T1pks-Nrps 1 CYP105AU1 
Terpene 1 CYP147F5 
Nrps-Arylpolyene-Ladderane 3 CYP107CE1; CYP107CF1; 
CYP163B4 
Indole 2 CYP156B6; CYP107U9 
Terpene 2 CYP125A20; CYP156C8 
© Central University of Technology, Free State
186 
 
 T1pks 3 CYP194B3; CYP194B4; CYP107BS2 
 T1pks-Nrps 3 CYP105AW1; CYP122A4; CYP107G2 




 T1pks-Nrps 1 CYP105AY1  
 T1pks 1 CYP107AD1  
 Bacteriocin-Nrps-
Lantipeptide-T1pks-Otherks 
3 CYP105AN3; CYP107E9; CYP155A5 
 Terpene 1 CYP105AV1 
 T1pks 1 CYP107CD1 
salu Butyrolactone 1 CYP107L43 
 Other 1 CYP1190A1 
 Other 1 CYP1192A1 
 T1pks-Nrps 1 CYP1191A1 
 Nrps 1 CYP107EB1 
 Transatpks-T1pks-Nrps 2 CYP163B9; CYP105AA13 
 T1pks 2 CYP105H9; CYP161A7 
 Transatpks-Nrps 3 CYP107B6; CYP1189A1; CYP1189A2 
 T3pks-Otherks-
Butyrolactone-Nrps 
2 CYP107F9; CYP163C3 
 T2pks-Oligosaccharide-
Nucleoside-Nrps 
2 CYP113D6; CYP157C28 
 Butyrolactone 1 CYP107AE9 
 Lantipeptide 1 CYP251G1 
 Terpene-T1pks 2 CYP161A6; CYP105H1 
sall Nrps 3 CYP107EL1; CYP163B8; 
CYP107EA2 
 Butyrolactone 1 CYP107L43 
 Other 1 CYP1190A1  
 Other 3 CYP147F21; CYP1060A2; 
CYP1192A1 
 T1pks 1 CYP1191A1  
 Transatpks-T1pks-Nrps 2 CYP163B9; CYP105AA13 
 T1pks 1 CYP105H9 
 Transatpks-Nrps 2 CYP1189A1; CYP1189A2 
 T3pks 1 CYP107F9 
 Otherks-Butyrolactone-Nrps 1 CYP163C3 
 T2pks-Oligosaccharide-
Nucleoside-Nrps 
2 CYP113D6; CYP157C28 
 Butyrolactone 1 CYP107AE9 
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Lantipeptide 1 CYP251G1 
T1pks 2 CYP161A6; CYP105H1 
Nrps 3 CYP107EA2; CYP163B8; 
CYP107EL1 
slv T3pks-Terpene-Nrps 1 CYP105N1 
Terpene 1 CYP170A1 
T3pks 1 CYP158A2 
sgu Other 1 CYP178B1 
Nrps 1 CYP163B10 
Terpene 1 CYP170A22 
Terpene 1 CYP180A9 
T2pks 1 CYP107AH4 
Terpene 1 CYP157K3 
Nrps 1 CYP113K5 
svt Other 1 CYP121A2 
T2pks-Nrps 3 CYP1029A3; CYP1423A1; 
CYP285A5 
Lantipeptide 1 CYP107LD1 
T2pks-Lantipeptide-Terpene 2 CYP154C11; CYP157A19 
stre Butyrolactone-T1pks-Nrps 1 CYP105BA3 
T1pks-Arylpolyene 3 CYP107EM1; CYP1198A1; 
CYP105BV1 
Terpene 1 CYP157C31 
T1pks 2 CYP105H1; CYP161A6 
Butyrolactone 1 CYP107AE10 
T3pks 1 CYP107F9 
T1pks 3 CYP105DE1; CYP105BS1; 
CYP1197A1  
Thiopeptide-T1pks 1 CYP184A8 
Nrps 1 CYP1196A1 
Transatpks-Nrps 2 CYP107CA2; CYP154D14 
Lantipeptide 1 CYP107L42 
Lantipeptide-Nrps 2 CYP163B; CYP1278B1 
Terpene-T1pks 1 CYP105H8 
T1pks-Butyrolactone-Nrps 1 CYP105BA3 
scw T1pks 2 CYP107L35; CYP105BT1 
Terpene 1 CYP170A17 
T1pks 1 CYP107W3 
Siderophore 1 CYP105AC8 
Terpene 2 CYP161C4; CYP183A4 
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Terpene 1 CYP157K4 
T3pks-Fused-Nrps 1 CYP105AC17 
sld T2pks 1 CYP105BW1 
Transatpks 2 CYP147K2; CYP1038A7 
Terpene 1 CYP147F28P 
Butyrolactone 1 CYP107AE8 
Other 1 CYP1469A2 
Terpene 1 CYP157C29 
T3pks-Nrps 2 CYP107F8; CYP105D25 
Terpene 1 CYP157C42 
T2pks-Oligosaccharide 1 CYP113D5 
Lassopeptide-Nrps 2 CYP1278B2; CYP163B11 
Other 1 CYP121A3 
T1pks 2 CYP161A5; CYP105H3 
T1pks 1 CYP186D1 
sxi Terpene 1 CYP157C32 
T1pks-Nrps 2 CYP1029A4; CYP285A6 




Terpene 1 CYP183W1 
T3pks-Terpene-Nrps 1 CYP107F11 
strm Terpene-Nrps 1 CYP154Q2 
Lantipeptide-Terpene 2 CYP157C26; CYP134A3 
Other 1 CYP105DF1 
Thiopeptide 2 CYP2238A1; CYP1048A3 
Terpene-Otherks 2 CYP154D15; CYP157C27 
T1pks 2 CYP105L3; CYP1995C1 
Terpene 1 CYP251F1 
strc T1pks-Transatpks-Terpene 1 CYP105AC15 
Nrps 2 CYP107LC1; CYP105BK2 
T2pks 1 CYP1064A5 
Fused 1 CYP1341E2 
T3pks 2 CYP157A20; CYP154C13 
T3pks-Terpene-Otherks 1 CYP123D1 
T1pks-Nrps 1 CYP105BA2 
T3pks-Nrps 2 CYP165E2; CYP165B8 
Terpene 1 CYP157C32 
samb T2pks-Butyrolactone 1 CYP154K2 
Indole 1 CYP156B15 
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 Terpene 1 CYP170A1  
 Oligosaccharide-T1pks-Nrps 2 CYP107EP1; CYP113B4 
 Terpene 1 CYP157K5 
 T1pks 2 CYP107EF1, CYP107EP1 
 T2pks-Butyrolactone 1 CYP154K2 
spri Oligosaccharide-Ectoine-
T2pks-Nrps-T1pks-Otherks 
3 CYP154A22; CYP107EH1; 
CYP113C2 
 Melanin 1 CYP124G6 
 T2pks-Oligosaccharide-Nrps-
Otherks 
3 CYP154B6; CYP113C2, CYP107EH1 
 T1pks-Ectoine-Otherks 1 CYP154A22 
scz Melanin 1 CYP124G2 
 Bacteriocin-T1pks-Nrps 1 CYP107BX7 
 Nrps 1 CYP154A18 
 T3pks 1 CYP107F4 
 Arylpolyene 1 CYP105D20 
scx Indole 1 CYP145C3 
 Terpene 1 CYP180A29 
 Terpene 1 CYP170A19 
 Terpene 2 CYP157C39; CYP183B5 
srw T1pks 1 CYP166A3 
 Bacteriocin-Nrps 1 CYP113K6 
 Other 1 CYP162B2 
 Other 2 CYP121A5; CYP154U7 
 T2pks-T3pks-Otherks 1 CYP158A14 




 Terpene 1 CYP170A23 
 Nrps 1 CYP2045A1 




 Terpene 1 CYP170A16 
 T2pks-Otherks 1 CYP105DD1 
sle T3pks-T1pks-Nrps 3 CYP107L35; CYP105BT1; CYP154B4  
 Terpene 1 CYP157K4 
 Lassopeptide 1 CYP102B20 
 Nrps 1 CYP113K3  
 Nrps-Transatpks-Terpene-
Otherks 
2 CYP107EG1; CYP105BR1 
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Terpene-T1pks 3 CYP107Q3; CYP105D28; CYP166A2 
T1pks 3 CYP154Z1; CYP1416A1; CYP2266A2 
Terpene 2 CYP183A4; CYP161C4 
T1pks-Siderophore 2 CYP107L33; CYP105AC8 
T3pks 1 CYP107F10 
Terpene 1 CYP170A17 
T1pks 1 CYP1418A1 
T1pks 1 CYP1031A3 
Other 1 CYP107AM11 
srn Terpene 3 CYP251A3; CYP157C21; CYP158A20 
Indole 2 CYP245A6; CYP244A3 
Nrps 2 CYP159A23; CYP157B32 
Thiopeptide 2 CYP183H3; CYP183G3 
Terpene 1 CYP251F2 
Lantipeptide-Nrps 1 CYP1207A10 
T3pks-Butyrolactone 1 CYP158A19 
Nrps 2 CYP107E12; CYP285D1 
spav Indole 2 CYP156B15; CYP183J3 
Terpene 1 CYP170A1 
Terpene 2 CYP157K6; CYP105D33 
slc T1pks 1 CYP147F26 
Terpene-T1pks-Nrps 2 CYP107FH2; CYP107B26 
T1pks-Nrps 1 CYP163G1 
Thiopeptide 1 CYP147F27 
Butyrolactone 1 CYP107AE12 
Melanin-Nrps 1 CYP107FV4 




T3pks-Nrps 1 CYP107F15 
strt Phosphonate-Nrps 1 CYP1618A1 
Thiopeptide-Terpene 1 CYP180B6 
Butyrolactone 1 CYP105B73 
Terpene 1 CYP183X4 
T3pks 1 CYP158A25 
Other 1 CYP107P31 
Terpene 1 CYP170A18 
Bacteriocin-T1pks 1 CYP158A24 
Phosphoglycolipid 1 CYP107E32 
Bacteriocin-Terpene-Nrps 2 CYP1722A3; CYP1618A2 
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sclf Terpene-T1pks-Nrps 3 CYP105BG1; CYP163B7; CYP251E1 
T3pks 1 CYP107F7 
Indole-Terpene-Nrps 2 CYP107NSF1; CYP107BY2 
T1pks-Nrps 1 CYP136E1 
Blactam-Nrps 1 CYP105M1 
Melanin 1 CYP124G5 
T1pks-Butyrolactone-Otherks 1 CYP107AL2 
T1pks 1 CYP154A14 
sgs Thiopeptide-Bacteriocin 1 CYP113V2 
Terpene 1 CYP170A10 
T1pks-Nrps 1 CYP247A3_ortholog 
T1pks 1 CYP105BC2 
Terpene 1 CYP180A26 
Lantipeptide-T1pks-Nrps 2 CYP208A9; CYP107BK3 
Nrps 1 CYP107KX1 
Other 2 CYP121A4; CYP154U6 




stsi Butyrolactone 1 CYP154K3 
Terpene 1 CYP170A15 
Nrps 2 CYP163B15; CYP113Z1 
sls Ladderane 1 CYP105B41 
Nrps 1 CYP163A5 
Nrps 1 CYP1424A1 
T3pks 1 CYP158A15 
Terpene 2 CYP183Y1; CYP157C22 
Terpene 1 CYP170A20 
Nrps-Siderophore 1 CYP107L32 
T2pks 1 CYP105B41 
snr T1pks 5 CYP105BV1; CYP1198A1; 
CYP107EM1; CYP1060A2; 
CYP147F29 
Terpene 1 CYP157C31 
T1pks 2 CYP105H1; CYP161A1 
Butyrolactone 1 CYP107AE10 
Other 1 CYP1248A3 
T1pks 1 CYP107EQ1 
T1pks 3 CYP107KZ1; CYP1420A1; 
CYP107A3 
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 T3pks 1 CYP107F9 
 Thiopeptide-Bacteriocin 1 CYP113D4 
 T1pks 1 CYP105AB15 
 Transatpks-Nrps 3 CYP107CA2; CYP154D14; 
CYP105AC16 
 Terpene 1 CYP105A7  
 Lantipeptide-Nrps 2 CYP163B; CYP1278B1 
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Table 4. 4 Comparative analysis of secondary metabolite biosynthetic gene clusters and P450s that 
are part of these clusters in mycobacterial species.   
 
Species code Cluster name Number of P450s P450 name 
maf T3pks-T1pks 1 CYP139A1 
 Other 3 CYP124A1; CYP128A1; CYP121A1 
mto T3pks-T1pks 1 CYP139A1 
 Nrps 1 CYP144A1 
 Other 3 CYP124A1; CYP128A1; CYP121A1 
mtf T3pks-T1pks  1 CYP139A1 
 Other 3 CYP124A1; CYP128A1; CYP121A1 
mra T3pks-T1pks 1 CYP139A1 
 T1pks 1 CYP139A1 
 Other 2 CYP124A1; CYP128A1 
mtu T3pks-T1pks 1 CYP139A1 
 Nrps 1 CYP144A1  
 Other 2 CYP124A1; CYP128A1 
mtul T3pks-T1pks 1 CYP139A1 
mtb Other 3 CYP121A1; CYP128A1; CYP124A1 
 Nrps 1 CYP144A1 
 T3pks-T1pks 1 CYP139A1  
mtz Other 3 CYP121A1; CYP128A1; CYP124A1 
 Nrps 1 CYP144A1 
 T3pks-T1pks 1 CYP139A1  
mtk Other 3 CYP121A1; CYP128A1; CYP124A1 
 Nrps 1 CYP144A1 
 T3pks-T1pks 1 CYP139A1 
mtg Other 2 CYP124A1; CYP102B25 
mtc T3pks-T1pks 1 CYP139A1  
 Other 3 CYP124A1; CYP128A1; CYP121A1 
mte T3pks-T1pks 1 CYP139A1 
 T1pks 3 CYP124A1; CYP128A1; CYP121A1 
 Other 3 CYP124A1; CYP128A1; CYP121A1 
mtub T3pks-T1pks 1 CYP139A1 
mtj T3pks-T1pks 1 CYP139A1 
 Nrps 1 CYP144A1  
 Other 3 CYP124A1; CYP128A1; CYP121A1 
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mtuc T3pks 1 CYP139A1 
Other 2 CYP124A1; CYP128A1 
mtx T3pks-T1pks 1 CYP139A1 
Nrps 1 CYP144A1 
mtuh T3pks 1 CYP139A1 
mtn T3pks-T1pks 1 CYP139A1 
mtd T3pks-T1pks 1 CYP139A1 
Other 2 CYP124A1; CYP128A1 
mce T3pks-T1pks 1 CYP139A1 
Other 3 CYP124A1; CYP128A1; CYP121A1 
mcq T3pks-T1pks 1 CYP139A1 
Other 2 CYP124A1; CYP128A1 
mcx T3pks-T1pks 1 CYP139A1 
Nrps 1 CYP144A1 
Other 3 CYP124A1; CYP128A1; CYP121A1 
mbo T3pks-T1pks 1 CYP139A1 
Other 3 CYP124A1; CYP128A1; CYP121A1 
mbb T3pks-T1pks 1 CYP139A1 
Other 3 CYP124A1; CYP128A1; CYP121A1 
mbk T3pks-T1pks 1 CYP139A1 
Other 3 CYP124A1; CYP128A1; CYP121A1 
mbm T3pks-T1pks 1 CYP139A1 
Other 3 CYP124A1; CYP128A1; CYP121A1 
mbt T3pks-T1pks 1 CYP139A1 
Other 3 CYP124A1; CYP128A1; CYP121A1 
mab T1pks-Nrps 1 CYP1110B1 
T2pks 1 CYP153A 
Nrps 1 CYP1128A 
Nrps 1 CYP135B 
mabb Nrps 1 CYP1128A 
Nrps 1 CYP135B 
mabl Nrps 1 CYP1128A 
Nrps 1 CYP135B 
maz T1pks-Nrps 1 CYP1110B1 
T2pks 1 CYP153A 
Nrps 1 CYP1128A 
Nrps 1 CYP135B 
may T1pks-Nrps 1 CYP1110B1 
T2pks 1 CYP153A 
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Nrps 1 CYP1128A 
Nrps 1 CYP135B 
mys Nrps 1 CYP135B 
Nrps 1 CYP1128A 
mav Nrps 1 CYP187A 
T1pks 1 CYP150A 
T1pks 1 CYP105NSF1 
T3pks-T1pks 1 CYP139A 
mpa T3pks-T1pks 1 CYP139A 
T1pks 1 CYP105NSF1 
T1pks-Nrps 1 CYP150A 
Nrps 1 CYP1034A 
T3pks 1 CYP187A 
mao T3pks 1 CYP187A 
Nrps 1 CYP1034A 
T1pks-Nrps 1 CYP150A 
T1pks 1 CYP105NSF1 
T3pks-T1pks 1 CYP139A 
T1pks 1 CYP144A 
mia T3pks 1 CYP187A 
T1pks-Nrps 1 CYP150A 
T1pks 2 CYP279A; CYP105U 
Other 1 CYP1122A1 
mit T3pks 2 CYP187A; CYP150A 
T1pks-Nrps 1 CYP150A 
T1pks 2 CYP279A; CYP105U 
Other 1 CYP1128A 
mie T3pks-T1pks 1 CYP187A 
T1pks 1 CYP150A 
T1pks 2 CYP279A; CYP105U 
mmm T3pks 1 CYP187A 
T1pks-Nrps 1 CYP150A 
T1pks 2 CYP279A; CYP105U 
mid T3pks 1 CYP1123A1 
Nrps 1 CYP126NSF1 
myv T1pks-Nrps 1 CYP135B 
mli Nrps 1 CYP143A3 
Nrps 2 CYP140A5; CYP125A6 
Other 1 CYP147G 
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T3pks-T1pks 1 CYP139A3 
mmae Nrps 1 CYP185A4 
T3pks-T1pks 1 CYP139A3 
Nrps 1 CYP143A3 
Nrps 2 CYP140A5; CYP125A6 
Other 1 CYP147G1 
T3pks 2 CYP187A; CYP187A 
Other 1 CYP164A3 
mmal T3pks 1 CYP187A 
T1pks-Nrps 1 CYP150A 
T1pks 3 CYP279A; CYP279A; CYP105U 
Other 2 CYP105Q; CYP189A 
mmv Nrps 1 CYP1128A 
mva T1pks-Nrps 1 CYP138C1 
msb T3pks 1 CYP185A1 
mcb Arylpolyene 3 CYP187A; CYP150A; CYP189A 
T1pks-Nrps 1 CYP138C 
T1pks 1 CYP292A 
mgi Terpene 1 CYP188A 
T1pks-Nrps 1 CYP138C2 
T1pks-Nrps 3 CYP189A; CYP150A; CYP187A 
msp Terpene 1 CYP188A 
T1pks-Nrps 1 CYP138C2 
Other 3 CYP189A; CYP150A; CYP187A 
msa T3pks 1 CYP135B 
Other 2 CYP187A; CYP150A 
T1pks-Nrps 1 CYP136NSF2 
mrh T1pks 2 CYP189A; CYP102NSF1 
T1pks-Nrps 1 CYP1121A1 
Nrps 1 CYP125A 
Nrps 1 CYP189A 
Arylpolyene 1 CYP124A 
Arylpolyene 1 CYP144A 
mne Other 1 CYP161NSF1 
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An interesting pattern was observed when comparing the number of P450s that are part of 
different types of secondary metabolite BGCs, revealing that dominant secondary metabolite 
BGCs are not necessarily dominant in terms of having P450s (Figure 4.5). In Streptomyces species, 
the secondary metabolite BGC, T1pks, the fourth dominant BGC (Figure 4.3A), has the highest 
number of P450s (82 P450s) (Figure 4.5A). Terpene, despite the dominant BGC in Streptomyces 
(Figure 4.3A), has the second highest number of P450s (Figure 4.5A). The same pattern was 
observed in mycobacterial species (Figure 4.5B) where ‘others’, the second dominant BGC (Figure 
4.3B), have the highest number of P450s compared to Nrps, the dominant BGC (Figure 4.3B), 
which has the second highest number of P450s (Figure 4.5B).     
Among 88 P450 families that are part of different secondary metabolite BGCs, some P450 
families are highly dominant in Streptomyces species (Figure 4.5C and Table 4.3), indicating their 
key role in the synthesis of different secondary metabolites. These P450 families (Figure 4.5C) 
were found to be the same that are highly populated in Streptomyces species, with some exceptions. 
This strongly indicates that these P450 families provide an advantage to Streptomyces species by 
generating diverse secondary metabolites, thus letting these species thrive in nature. Despite P450s 
families such as CYP102, CYP159, CYP125, CYP1035, CYP1038 and CYP155 being highly 
populated in Streptomyces species, their percentage contribution as part of secondary metabolite 
BGCs is quite negligible (Table 4.5), indicating further selectivity in terms of which P450s should 
be part of secondary metabolite BGCs. Mycobacterial species’ secondary metabolite BGC P450 
profiles (Figure 4.5D) are contrasted with Streptomyces species, where the dominant P450 families 
are not necessarily dominant as part of secondary metabolite BGCs. Ten P450 families, namely 
CYP51, CYP123, CYP125, CYP130, CYP135, CYP136, CYP138, CYP140, CYP144 and 
CYP1128, are conserved and highly populated across 60 mycobacterial species (Parvez et al., 
© Central University of Technology, Free State
198 
 
2016). However, none of these P450 families is dominant as part of different secondary metabolite 
BGCs (Figure 4.5D and Table 4.5). In fact, P450 families such as CYP123, CYP130 and CYP1128 
are not found to be part of any secondary metabolite BGCs and P450 families such as CYP136, 
CYP125, CYP138 and CYP140 are rarely present as part of different secondary metabolite BGCs 
(Table 4.4). Their percentage contribution as part of secondary metabolite BGCs is thus very low 
(Figure 4.5D and Table 4.5). The CYP139 P450 family was found to be the dominant family as 
part of secondary metabolite BGCs (Figure 4.5D). Although eight P450 families, namely CYP124, 
CYP121, CYP105, CYP125, CYP102, CYP147, CYP136 and CYP161, which are part of 
secondary metabolite BGCs, were commonly found between the genera Streptomyces and 
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Table 4. 5 Comparative analysis of P450s that are part of secondary metabolite biosynthetic gene 
clusters between the genera Streptomyces and Mycobacterium. The P450 families commonly 
found in both genera are highlighted in bold font.  
Streptomyces Mycobacterium 
P450 family No. of P450s P450 family No. of P450s 
CYP107 127 CYP139 32 
CYP105 95 CYP124 24 
CYP157 27 CYP128 22 
CYP154 23 CYP121 17 
CYP163 22 CYP187 14 
CYP170 21 CYP150 13 
CYP113 19 CYP144 10 
CYP183 19 CYP105 9 
CYP158 17 CYP1128 8 
CYP124 12 CYP135 8 
CYP180 11 CYP189 6 
CYP156 10 CYP279 6 
CYP161 10 CYP138 4 
CYP147 9 CYP1110 3 
CYP285 7 CYP125 3 
CYP251 6 CYP153 3 
CYP121 5 CYP102 2 
CYP162 5 CYP1034 2 
CYP1029 4 CYP140 2 
CYP1189 4 CYP143 2 
CYP125 3 CYP147 2 
CYP1278 3 CYP185 2 
CYP1423 3 CYP188 2 
CYP178 3 CYP1121 1 
CYP184 3 CYP1122 1 
CYP247 3 CYP126 1 
CYP1005 2 CYP136 1 
CYP1013 2 CYP161 1 
CYP1035 2 CYP164 1 
CYP1037 2 CYP292 1 
CYP1048 2 CYP1123 1 
CYP1060 2   
CYP1190 2   
CYP1191 2   
CYP1192 2   
CYP1198 2   
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CYP1420 2   
CYP155 2   
CYP1618 2   
CYP165 2   
CYP166 2   
CYP171 2   
CYP179 2   
CYP181 2   
CYP194 2   
CYP208 2   
CYP245 2   
CYP102 1   
CYP1031 1   
CYP1038 1   
CYP1039 1   
CYP1041 1   
CYP1056 1   
CYP1057 1   
CYP1058 1   
CYP1059 1   
CYP1064 1   
CYP1193 1   
CYP1194 1   
CYP1196 1   
CYP1197 1   
CYP1207 1   
CYP1223 1   
CYP122 1   
CYP123 1   
CYP1248 1   
CYP1274 1   
CYP1341 1   
CYP134 1   
CYP136 1   
CYP1373 1   
CYP1416 1   
CYP1418 1   
CYP1424 1   
CYP145 1   
CYP1469 1   
CYP146 1   
CYP159 1   
CYP1722 1   
CYP186 1   
CYP1995 1   
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CYP2045 1   
CYP2238 1   
CYP2266 1   
CYP244 1   
CYP246 1   
CYP268 1   
CYP283 1   
 
 
4.3. Functional relevance of secondary metabolite biosynthetic gene clusters and associated 
P450s in Streptomyces and Mycobacterium 
Among the P450 families involved in secondary metabolite production, 88 P450 families are 
uniquely present in Streptomyces species compared to mycobacterial species (Figure 4.1 and Table 
4.5). P450 families, namely CYP105, CYP107, CYP161, and CYP183, which are highly populated 
in Streptomyces species compared to mycobacterial species, were found to be involved in 
secondary metabolite production (Figure 4.5C). This strongly suggests that these P450 families 
have been populated in Streptomyces species owing to their importance and necessity in secondary 
metabolite production. Therefore, the diversity among these P450 families, judged by the large 
number of P450 subfamilies, presumably serves to increase the resultant chemical diversity further 
across different Streptomyces species. It is well established that P450s are one of the key enzymes 
contributing to the diversity of secondary metabolites in organisms (Greule et al., 2018). In 
contrast to the P450 families highly populated in Streptomyces species, P450 families that are 
highly populated in mycobacterial species such as CYP125, CYP124, CYP108, CYP140 and 
CYP268 are involved in steroid (cholesterol) and hydrocarbon (lipids, alkenes, long chain acetate 
and ketone) hydroxylation (Hasemann et al., 1994, Mve-Obiang et al., 2005, Johnston et al., 2009, 
McLean et al., 2009, Ouellet et al., 2010, Child et al., 2018), suggesting that these P450 families 
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possibly help mycobacterial species to assimilate the host compounds. It is noteworthy that results 
from this study revealed that some of these P450 families are rarely (CYP125 and CYP140) or not 
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CHAPTER 5: CONCLUSION AND FUTURE PERSPECTIVES 
Streptomyces species are generally saprophytes living in soil or decaying vegetation, where the 
rule of survival of the fittest applies. Some studies reported symbiosis in Streptomyces, including 
parasitism. In response to this type of ecological niche, Streptomyces adapted to produce different 
secondary metabolites, which are harmful to other bacteria and thus Streptomyces species, can 
survive and utilise the readily available carbon sources in their environment. In contrast to 
Streptomyces species, mycobacterial species are well-known pathogens of humans and other 
animals, despite some saprophytes being present in this genus. The pathogenic nature of 
mycobacterial species forced them to adapt to lifestyles such as living in a host where evading the 
host’s immune system and utilising host carbon sources for survival are the prime tasks.  It is clear 
that different lifestyles influenced the P450 profiles in Streptomyces and Mycobacterium, hence 
the differences observed between the two genera in terms of number and type of secondary 
metabolite BGCs and P450s that are associated with secondary metabolite BGCs. The presence of 
quite a large number of polyketide synthase BGCs (identified in this study) that are involved in 
the production of unique lipids and glycolipid conjugates further strengthens the argument that 
Mycobacterium P450s are involved in lipid metabolism. The saprophytic and symbiotic lifestyle 
of Streptomyces resulted in the highest diversity of secondary metabolite BGCs and P450s, thus 
helping these organisms to generate chemically diverse secondary metabolites to adapt to different 
ecological niches. For this reason, Streptomyces species have been found to have large and diverse 
secondary metabolite BGCs and P450s compared to mycobacterial species.  Future work involves 
culturing of Streptomyces species and mycobacterial species that are identified to produce the 
highest number of different types of secondary metabolites and assessing the properties of 
secondary metabolites produced by these species. 
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